Open in Screener

LFST

LifeStance Health Group Inc

May 21 • 04:00PM ET

7.46

-0.22 -2.86 %

Healthcare • Medical Care Facilities • USA • Mid • NASD

| Held by: IJR VTI VB IWM VBK VXF SPSM DFAS DFSV IJT

Index	RUT	P/E	126.01	EPS (ttm)	0.06	Insider Own	41.96%	Shs Outstand	387.81M	Perf Week	-5.45%
Market Cap	2.89B	Forward P/E	37.37	EPS next Y	0.20	Insider Trans	-27.09%	Shs Float	225.09M	Perf Month	7.96%
Enterprise Value	3.18B	PEG	0.22	EPS next Q	0.03	Inst Own	50.01%	Short Float	3.07%	Perf Quarter	4.34%
Income	23.20M	P/S	1.94	EPS this Y	580.33%	Inst Trans	4.72%	Short Ratio	1.66	Perf Half Y	20.32%
Sales	1.49B	P/B	1.96	EPS next Y	46.72%	ROA	1.09%	Short Interest	6.90M	Perf YTD	5.97%
Book/sh	3.81	P/C	14.85	EPS next 5Y	171.36%	ROE	1.58%	52W High	8.89 -16.09%	Perf Year	31.57%
Cash/sh	0.50	P/FCF	20.28	EPS past 3/5Y	- -	ROIC	1.23%	52W Low	3.74 99.47%	Perf 3Y	-10.77%
Dividend Est.	-	EV/EBITDA	31.52	Sales past 3/5Y	18.33% 30.44%	Gross Margin	28.96%	Volatility	3.07% 4.12%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.12	EPS Y/Y TTM	164.03%	Oper. Margin	3.11%	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	16.46%	Profit Margin	1.55%	RSI (14)	50.00	Recom	1.30
Dividend Gr. 3/5Y	- -	Current Ratio	1.48	EPS Q/Q	1900.00%	SMA20	-2.45%	Beta	1.19	Target Price	10.72
Payout	0.00%	Debt/Eq	0.32	Sales Q/Q	21.17%	SMA50	6.95%	Rel Volume	0.49	Prev Close	7.68
Employees	10961	LT Debt/Eq	0.28	Earnings	May 07 BMO	SMA200	17.12%	Avg Volume	4.15M	Price	7.46
IPO	Jun 10, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	455.56% 4.14%	Trades		Volume	2,055,131	Change	-2.86%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Overweight	$8
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$8
Jul-25-25	Initiated	BTIG Research	Buy	$8
May-27-25	Upgrade	UBS	Neutral → Buy	$8.50
Apr-08-25	Initiated	KeyBanc Capital Markets	Overweight	$9
Apr-03-25	Initiated	Canaccord Genuity	Buy	$8
Dec-16-24	Upgrade	Goldman	Neutral → Buy	$10
Jan-03-24	Initiated	Barclays	Underweight	$7
May-15-23	Downgrade	TD Cowen	Outperform → Market Perform	$8 → $9
Jan-06-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$8
Nov-07-22	Resumed	Jefferies	Buy	$7.25
Mar-17-22	Downgrade	UBS	Buy → Neutral	$19 → $10
Nov-09-21	Downgrade	JP Morgan	Overweight → Neutral	$24 → $12
Sep-10-21	Initiated	Cowen	Outperform	$18
Aug-16-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$36 → $16
Jul-06-21	Initiated	William Blair	Outperform
Jul-06-21	Initiated	Morgan Stanley	Overweight	$36
Jul-06-21	Initiated	JP Morgan	Overweight	$36
Jul-06-21	Initiated	Jefferies	Buy	$36
Jul-06-21	Initiated	Goldman	Neutral	$25

Show Previous Ratings

May-07-26 10:18PM	LifeStance Health Group Announces Pricing of Secondary Public Offering (GlobeNewswire) +20.24% -12.99%
05:00PM	LifeStance Health Group, Inc. Q1 2026 Earnings Call Summary (Moby)
04:51PM	LifeStance Health Group Announces Launch of Secondary Public Offering (GlobeNewswire)
06:09AM	LifeStance Health: Q1 Earnings Snapshot (Associated Press)
06:00AM	LifeStance Reports First Quarter 2026 Results (GlobeNewswire)
09:23AM	Loading…
May-06-26 09:23AM	LifeStance Health Group Inc (LFST) Q1 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Apr-29-26 04:10PM	LifeStance to Present at Upcoming Investor Conferences (GlobeNewswire)
Apr-27-26 06:15PM	LifeStance Health Group Set to Join S&P SmallCap 600 (PR Newswire) +5.50%
Apr-16-26 04:10PM	LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026 (GlobeNewswire)
Apr-09-26 09:00AM	LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale (PR Newswire)
Feb-28-26 02:14AM	Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here's Why (Insider Monkey)
Feb-25-26 04:48PM	LifeStance Health Group Announces Launch of Secondary Public Offering (GlobeNewswire) -6.07%
04:02PM	LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:29PM	LifeStance Health Group Q4 Earnings Call Highlights (MarketBeat)
12:34PM	LifeStance Health Group, Inc. Q4 2025 Earnings Call Summary (Moby)
12:15PM	Loading…
12:15PM	LifeStance Health Group (LFST) Q4 Earnings and Revenues Top Estimates (Zacks)
06:45AM	LifeStance Health Group (NASDAQ:LFST) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 12.7% (StockStory)
06:22AM	LifeStance Health: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LifeStance Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-24-26 07:24AM	LifeStance Health Group Inc (LFST) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-09-26 04:10PM	LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026 (GlobeNewswire)
Feb-02-26 05:20PM	DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Jan-22-26 02:14PM	Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes (Insider Monkey)
Dec-22-25 06:05AM	2026 Medical Utilization Forecasts Support BTIG's Bullish View on LifeStance (LFST) (Insider Monkey)
Dec-11-25 10:33PM	Spotting Winners: LifeStance Health Group (NASDAQ:LFST) And Outpatient & Specialty Care Stocks In Q3 (StockStory)
Nov-28-25 09:55AM	Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet (Zacks)
Nov-20-25 11:02PM	3 Reasons to Sell LFST and 1 Stock to Buy Instead (StockStory)
Nov-13-25 12:37AM	The 5 Most Interesting Analyst Questions From LifeStance Health Group's Q3 Earnings Call (StockStory)
Nov-12-25 09:55AM	Wall Street Analysts See a 33.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High? (Zacks)
Nov-08-25 05:11AM	LifeStance (LFST) Soars 30% on Q3 Earnings Blowout (Insider Monkey)
12:32AM	Loading…
Nov-07-25 12:32AM	LFST Q3 Deep Dive: Productivity Initiatives and Tech Investment Drive Behavioral Health Growth (StockStory)
Nov-06-25 07:15AM	LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3 (Zacks) +29.94%
06:12AM	LifeStance Health Group's (NASDAQ:LFST) Q3 Sales Top Estimates (StockStory)
06:00AM	LifeStance Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-05-25 09:00AM	Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season (PR Newswire)
07:34AM	What To Expect From LifeStance Health Group Inc (LFST) Q3 2025 Earnings (GuruFocus.com)
Nov-04-25 10:22PM	LifeStance Health Group (LFST) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-28-25 04:10PM	LifeStance to Present at the UBS Global Healthcare Conference (GlobeNewswire)
09:00AM	Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care (PR Newswire)
Oct-16-25 04:10PM	LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025 (GlobeNewswire)
Oct-10-25 03:50PM	LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know (StockStory) -5.78%
Oct-08-25 12:00PM	All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy (Zacks)
Sep-26-25 10:21AM	Just How Healthy Is the Business of Mental Health? (Barrons.com)
10:09AM	The Stock Market Is Up, but the Dollar Is Down. What It Means for You. (Barrons.com)
Sep-15-25 11:31PM	Winners And Losers Of Q2: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks (StockStory)
Sep-12-25 12:03AM	3 Reasons LFST is Risky and 1 Stock to Buy Instead (StockStory)
Sep-10-25 03:11PM	Why LifeStance Health Group (LFST) Shares Are Getting Obliterated Today (StockStory) -5.74%
Aug-26-25 04:10PM	LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference (GlobeNewswire)
Aug-22-25 09:00AM	Sarah Personette Appointed to LifeStance Board of Directors (PR Newswire)
Aug-17-25 06:20PM	LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion (Insider Monkey)
Aug-15-25 11:02AM	LifeStance (LFST) Extends Rally to 5th Day on Strong Investor Confidence (Insider Monkey)
Aug-14-25 01:46PM	LifeStance (LFST) Extends 4-Day Run on Strong Earnings (Insider Monkey) +7.93%
01:33AM	The 5 Most Interesting Analyst Questions From LifeStance Health Group's Q2 Earnings Call (StockStory)
Aug-12-25 03:23AM	LFST Q2 Deep Dive: Productivity Initiatives and Technology Investments Drive Margin Expansion (StockStory)
Aug-11-25 07:45AM	UBS Raised the Firm's PT on LifeStance Health Group (LFST), Kept a Buy Rating (Insider Monkey)
Aug-08-25 02:21PM	Why LifeStance Health Group (LFST) Stock Is Up Today (StockStory) +13.21%
Aug-07-25 01:45PM	LifeStance Health Group's (NASDAQ:LFST) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations (StockStory)
07:15AM	LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:11AM	LifeStance Health: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LifeStance Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 11:08PM	LifeStance Health Group (LFST) Reports Earnings Tomorrow: What To Expect (StockStory)
Aug-01-25 06:47AM	Lifestance Health Group (LFST) Rated as a Buy at BTIG amid Commercially Insured Patients Boost (Insider Monkey)
12:38AM	3 Small-Cap Stocks We Find Risky (StockStory)
Jul-23-25 11:25AM	LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer (Insider Monkey)
Jul-22-25 09:00AM	'Stressflation' is Here: 83% of Americans Say Today's Economic Climate is Taking a Toll on Their Mental Health (PR Newswire)
Jul-17-25 04:10PM	LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 (GlobeNewswire)
Jul-14-25 12:06AM	3 Reasons to Avoid LFST and 1 Stock to Buy Instead (StockStory)
Jul-11-25 03:30PM	Why LifeStance Health Group (LFST) Stock Is Trading Lower Today (StockStory)
07:17AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
Jul-07-25 09:10AM	Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10 (Insider Monkey)
Jul-02-25 01:35AM	5 Revealing Analyst Questions From LifeStance Health Group's Q1 Earnings Call (StockStory)
Jun-27-25 12:00PM	LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jun-16-25 09:35AM	After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST) (Zacks)
Jun-10-25 12:31PM	LFST Q1 Earnings Call: Outpatient Behavioral Health Sees Stable Growth, Margin Improvement, and Shifts in Clinician Incentives (StockStory)
Jun-05-25 09:55AM	Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet (Zacks)
May-28-25 04:10PM	LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference (GlobeNewswire)
May-27-25 11:35AM	Southwest bag fees, LifeStance upgrade, AutoZone earnings (Yahoo Finance Video) +10.38%
May-25-25 11:31PM	Q1 Earnings Highlights: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks (StockStory)
May-14-25 09:00AM	LifeStance Names Vaughn Paunovich as Chief Technology Officer (PR Newswire)
May-08-25 12:00PM	LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why (Zacks) +5.44%
09:35AM	Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround (Zacks)
03:14AM	LifeStance Health Group Inc (LFST) Q1 2025 Earnings Call Highlights: A Promising Start with ... (GuruFocus.com)
May-07-25 07:10AM	LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1 (Zacks) -15.88%
06:00AM	LifeStance Reports First Quarter 2025 Results (GlobeNewswire)
May-06-25 04:05PM	Lifeist Announces Leadership Changes to Advance Strategy of Streamlining Operations and Improving Organizational Efficiency (GlobeNewswire)
May-05-25 09:55AM	Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade (Zacks)
Apr-30-25 10:01AM	LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-29-25 09:05AM	3 of Wall Street's Favorite Stocks with Questionable Fundamentals (StockStory)
Apr-22-25 06:12AM	LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion (Seeking Alpha)
Apr-21-25 04:10PM	LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025 (GlobeNewswire) -8.06%
Apr-18-25 09:02AM	3 Healthcare Stocks with Questionable Fundamentals (StockStory)
Apr-16-25 05:11AM	3 Reasons LFST is Risky and 1 Stock to Buy Instead (StockStory)
Apr-15-25 09:00AM	LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions (PR Newswire)
Apr-10-25 11:38AM	Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains? (Zacks)
11:37AM	LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
09:55AM	Wall Street Analysts See a 26.63% Upside in LifeStance Health (LFST): Can the Stock Really Move This High? (Zacks)
Mar-21-25 09:55AM	LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-13-25 05:01AM	Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH) (StockStory)
Feb-28-25 02:17AM	LifeStance Health Group Inc (LFST) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:49AM	Q4 2024 Lifestance Health Group Inc Earnings Call (Thomson Reuters StreetEvents)

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Executive ChairmanMr. Kenneth Alan Burdick J.D.

CEO & DirectorMr. David Patrick Bourdon

CFO & TreasurerMr. Ryan Bruce McGroarty

Chief Technology OfficerMr. Vukasin Paunovich

Chief Legal Officer & SecretaryMr. Ryan Pardo J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bessler Robert	Director	May 12 '26	Sale	8.02	575,034	4,611,773	986,931	May 14 05:30 PM
Shuey Eric	Director	May 12 '26	Sale	8.02	243,362	1,951,763	867,562	May 14 05:30 PM
BLACK DARREN M.	Director	May 12 '26	Sale	8.02	5,899,661	47,315,281	23,310,115	May 14 05:30 PM
TPG GP A, LLC	10% Owner	May 12 '26	Sale	8.02	28,281,943	226,821,183	111,744,614	May 14 04:07 PM
Bessler Robert	Director	May 07 '26	Sale	8.55	75,000	641,250	1,236,948	May 11 05:37 PM
Bessler Robert	Director	May 07 '26	Proposed Sale	8.55	75,000	641,580		May 07 04:45 PM
Bessler Robert	Director	Apr 24 '26	Sale	7.05	62,147	438,136	1,274,448	Apr 27 04:22 PM
Bessler Robert	Director	Apr 23 '26	Sale	7.00	7,752	54,264	1,305,521	Apr 27 04:22 PM
Bessler Robert	Director	Apr 24 '26	Proposed Sale	7.05	62,147	438,074		Apr 24 04:11 PM
Bessler Robert	Director	Apr 21 '26	Sale	7.01	5,101	35,758	1,309,397	Apr 23 04:25 PM
Bessler Robert	Director	Apr 23 '26	Proposed Sale	7.00	7,752	54,267		Apr 23 04:06 PM
Bessler Robert	Director	Apr 21 '26	Proposed Sale	7.01	5,101	35,749		Apr 21 04:33 PM
TPG GP A, LLC	10% Owner	Mar 02 '26	Sale	7.01	20,685,061	145,002,278	140,026,557	Mar 04 04:32 PM
BLACK DARREN M.	Director	Mar 02 '26	Sale	7.01	4,314,939	30,247,722	29,209,776	Mar 04 04:05 PM
Bessler Robert	Director	Dec 19 '25	Sale	7.04	119,942	844,392	1,318,983	Dec 23 07:53 PM
Bessler Robert	Director	Dec 22 '25	Sale	7.04	1,701	11,975	1,318,133	Dec 23 07:53 PM
Bessler Robert	Director	Dec 22 '25	Proposed Sale	7.04	1,701	11,975		Dec 22 04:30 PM
Bessler Robert	Director	Dec 18 '25	Sale	7.00	6,442	45,094	1,378,954	Dec 19 04:55 PM
Varanakis Ann	Chief People Officer	Dec 17 '25	Sale	6.90	50,000	345,000	315,610	Dec 19 04:49 PM
Bessler Robert	Director	Dec 19 '25	Proposed Sale	7.04	119,942	844,056		Dec 19 04:07 PM
Bessler Robert	Director	Dec 18 '25	Proposed Sale	7.00	6,442	45,113		Dec 18 04:02 PM
Varanakis Ann	Officer	Dec 17 '25	Proposed Sale	6.90	50,000	344,843		Dec 17 04:13 PM
Bessler Robert	Director	Dec 12 '25	Sale	7.01	79,630	558,206	1,382,175	Dec 16 07:49 PM
Bessler Robert	Director	Dec 15 '25	Sale	7.00	12,371	86,597	1,375,989	Dec 16 07:49 PM
Bessler Robert	Director	Dec 15 '25	Proposed Sale	7.00	12,371	86,622		Dec 15 04:12 PM
Bessler Robert	Director	Dec 12 '25	Proposed Sale	7.01	79,630	558,222		Dec 12 04:17 PM
Miller Lisa K	See Remarks	Nov 21 '25	Sale	6.43	57,240	368,053	261,292	Nov 25 04:25 PM
Miller Lisa K	Officer	Nov 21 '25	Proposed Sale	6.43	57,240	368,143		Nov 21 04:38 PM
Silversmith Partners I GP, LLC	Member of 10% Group	Aug 18 '25	Sale	5.07	3,592,357	18,213,250	14,324,197	Aug 20 04:49 PM
BLACK DARREN M.	Director	Aug 18 '25	Sale	5.07	8,407,643	42,626,750	33,524,715	Aug 20 04:47 PM
SUMMIT PARTNERS L P	10% Owner	Aug 18 '25	Sale	5.07	8,407,643	42,626,750	33,524,715	Aug 20 04:34 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	894,098	4,837,070		Aug 18 08:42 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	2,471,741	13,372,119		Aug 18 08:41 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	226,518	1,225,462		Aug 18 08:39 PM
SUMMIT PARTNERS GROWTH EQUITY	Owner	Aug 18 '25	Proposed Sale	5.41	3,214,648	17,391,246		Aug 18 08:37 PM
SUMMIT PARTNERS GROWTH EQUITY	Owner	Aug 18 '25	Proposed Sale	5.41	5,148,494	27,853,353		Aug 18 08:36 PM
SUMMIT PARTNERS ENTREPRENEUR A	Owner	Aug 18 '25	Proposed Sale	5.41	4,804	25,990		Aug 18 08:34 PM
SUMMIT INVESTORS GE IX-VC IV,	Owner	Aug 18 '25	Proposed Sale	5.41	35,938	194,425		Aug 18 08:32 PM
SUMMIT INVESTORS GE IX/VC IV (	Owner	Aug 18 '25	Proposed Sale	5.41	3,759	20,336		Aug 18 08:30 PM
Burdick Kenneth A	Director	Aug 08 '25	Buy	4.36	47,670	207,751	3,416,571	Aug 12 04:30 PM
Burdick Kenneth A	Director	Aug 08 '25	Buy	4.30	46,511	199,997	46,511	Aug 12 04:30 PM
Burdick Kenneth A	Director	Aug 11 '25	Buy	4.53	20,000	90,545	3,436,571	Aug 12 04:30 PM
Ramtekkar Ujjwal	Chief Medical Officer	Jun 16 '25	Sale	5.17	9,519	49,213	103,916	Jun 18 04:00 PM
Ramtekkar Ujjwal	Officer	Jun 16 '25	Proposed Sale	5.17	9,519	49,213		Jun 16 04:09 PM
Ramtekkar Ujjwal	Chief Medical Officer	Jun 05 '25	Sale	5.94	16,000	95,040	113,435	Jun 09 05:00 PM
Ramtekkar Ujjwal	Officer	Jun 05 '25	Proposed Sale	5.94	16,000	94,961		Jun 05 04:45 PM

Open in Screener

ODTX

Odyssey Therapeutics Inc

May 21 • 04:00PM ET

17.74

+0.77 4.57 %

Healthcare • Biotechnology • USA • Small • NASD

ODTX Odyssey Therapeutics Inc daily Stock Chart

Index	-	P/E	-	EPS (ttm)	-	Insider Own	51.48%	Shs Outstand	47.17M	Perf Week	2.42%
Market Cap	839.63M	Forward P/E	-	EPS next Y	-	Insider Trans	20.72%	Shs Float	22.97M	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	18.44%	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	8.04%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	20.30 -12.61%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	-6.04% -	ROIC	-	52W Low	15.35 15.57%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.55% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	2.14%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	2.14%	Rel Volume	0.61	Prev Close	16.97
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	2.14%	Avg Volume	639.31K	Price	17.74
IPO	May 08, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	408,154	Change	4.57%

May-11-26 08:31AM

Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip

(GuruFocus.com) +6.27%

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.

FounderDr. Gary D. Glick Ph.D.

Chief Financial OfficerMr. Jason Haas M.B.A.

Senior Vice President of Strategy & Business DevelopmentMr. Collin Todd

Ph.D.Prof. Eicke Latz M.D.

Scientific Co-FounderDr. Kim Lewis Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TPG GP A, LLC	Former 10% Owner	May 11 '26	Buy	18.00	1,388,889	25,000,002	3,690,146	May 13 05:10 PM
Dimension Capital II, L.P.	Director	May 08 '26	Buy	18.00	1,111,111	19,999,998	3,333,516	May 12 05:37 PM
SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	May 11 '26	Buy	18.00	555,555	9,999,990	1,831,383	May 11 09:11 PM
SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	May 11 '26	Sale	18.00	1,780	32,040	440,981	May 11 09:11 PM
LEIDEN JEFFREY M	Director	May 08 '26	Buy	20.00	5,000	100,000	270,198	May 11 08:35 PM
Haas Jason	Chief Financial Officer	May 08 '26	Buy	20.00	1,000	20,000	62,908	May 11 08:32 PM
Li Nan (LN)	Director	May 11 '26	Buy	18.00	1,111,111	19,999,998	3,333,516	May 11 08:30 PM
Chu Shelley	Director	May 11 '26	Buy	18.00	11,111	199,998	11,111	May 11 08:30 PM

Open in Screener

SION

Sionna Therapeutics Inc

May 21 • 04:00PM ET

41.75

+2.25 5.70 %

Healthcare • Biotechnology • USA • Small • NASD

SION Sionna Therapeutics Inc daily Stock Chart

Peers: ARQT KRYS TARS BEAM NTLA

| Held by: VTI XBI IWM IBB VXF IWO VTWO SCHA VFMO SBIO

Index	RUT	P/E	-	EPS (ttm)	-1.92	Insider Own	41.65%	Shs Outstand	45.08M	Perf Week	-2.38%
Market Cap	1.89B	Forward P/E	-	EPS next Y	-2.83	Insider Trans	-11.18%	Shs Float	26.34M	Perf Month	-3.36%
Enterprise Value	1.68B	PEG	-	EPS next Q	-0.64	Inst Own	63.09%	Short Float	16.06%	Perf Quarter	17.64%
Income	-85.56M	P/S	-	EPS this Y	-36.99%	Inst Trans	6.12%	Short Ratio	11.38	Perf Half Y	6.72%
Sales	0.00M	P/B	6.53	EPS next Y	-9.89%	ROA	-25.36%	Short Interest	4.23M	Perf YTD	1.48%
Book/sh	6.39	P/C	8.72	EPS next 5Y	-19.20%	ROE	-26.74%	52W High	48.44 -13.82%	Perf Year	209.26%
Cash/sh	4.79	P/FCF	-	EPS past 3/5Y	-22.66% -	ROIC	-28.98%	52W Low	12.42 236.15%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.03% 8.20%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.48%	Oper. Margin	-	ATR (14)	3.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	22.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.47	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	22.60	EPS Q/Q	-58.94%	SMA20	2.38%	Beta	1.31	Target Price	51.60
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	5.29%	Rel Volume	0.63	Prev Close	39.50
Employees	59	LT Debt/Eq	0.02	Earnings	May 12 BMO	SMA200	16.92%	Avg Volume	371.83K	Price	41.75
IPO	Feb 07, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.73% -	Trades		Volume	236,936	Change	5.70%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-26	Initiated	Wedbush	Outperform	$53
Feb-24-26	Initiated	Citizens	Mkt Outperform	$63
Dec-01-25	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$24
Nov-19-25	Initiated	BTIG Research	Buy	$50
Sep-03-25	Initiated	RBC Capital Mkts	Sector Perform	$22
Sep-03-25	Initiated	Raymond James	Strong Buy	$45
Mar-04-25	Initiated	TD Cowen	Buy
Mar-04-25	Initiated	Stifel	Buy	$32
Mar-04-25	Initiated	Guggenheim	Buy	$45

May-13-26 08:00AM	Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference (GlobeNewswire) +5.32%
May-12-26 07:00AM	Sionna Therapeutics Reports First Quarter 2026 Financial Results (GlobeNewswire) -10.90%
Apr-27-26 07:00AM	Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis (GlobeNewswire)
Apr-07-26 07:00AM	Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium (GlobeNewswire)
Mar-02-26 07:00AM	Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.17%
08:00AM	Loading…
Feb-23-26 08:00AM	Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences (GlobeNewswire)
Feb-15-26 04:41AM	Sionna Therapeutics Maps Mid-2026 CF Catalysts, Highlights NBD1 Stabilizers at Guggenheim Summit (MarketBeat)
Feb-04-26 07:00AM	Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 (GlobeNewswire) -7.12%
Jan-05-26 07:00AM	Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-23-25 09:33AM	Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls (The Fly)
Nov-24-25 07:00AM	Sionna Therapeutics to Participate in Upcoming December Investor Conferences (GlobeNewswire)
Nov-14-25 06:00PM	Bitdeer, Pacira BioSciences, Garrett Motion, and More Stocks See Action From Activist Investors (Barrons.com) +7.92%
Nov-05-25 07:00AM	Sionna Therapeutics Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:00AM	Sionna Therapeutics to Participate in Upcoming November Investor Conferences (GlobeNewswire)
Oct-31-25 05:42PM	Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors (Barrons.com) -5.63%
01:15PM	Loading…
Oct-24-25 01:15PM	Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference (GlobeNewswire)
Oct-21-25 07:00AM	Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis (GlobeNewswire) +31.99%
Oct-01-25 04:05PM	Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference (GlobeNewswire)
Sep-15-25 12:00PM	All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy (Zacks)
Sep-09-25 09:55AM	Wall Street Analysts See a 66.51% Upside in Sionna Therapeutics, Inc. (SION): Can the Stock Really Move This High? (Zacks) +13.32%
Sep-08-25 08:00AM	Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer (GlobeNewswire) -9.92%
Aug-27-25 07:00AM	Sionna Therapeutics to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-25-25 07:00AM	Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis (GlobeNewswire)
Aug-11-25 07:00AM	Sionna Therapeutics Reports Second Quarter 2025 Financial Results (GlobeNewswire) +13.36%
Jun-06-25 11:00AM	Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model (GlobeNewswire) +7.42%
Jun-04-25 01:54PM	Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial (Benzinga) +9.12%
07:00AM	Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis (GlobeNewswire)
Jun-03-25 07:00AM	Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-22-25 07:00AM	Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference (GlobeNewswire)
May-12-25 07:00AM	Sionna Therapeutics Reports First Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Loading…
Apr-30-25 07:00AM	Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025 (GlobeNewswire)
Mar-20-25 07:00AM	Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-15-25 04:43PM	Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month (Insider Monkey)
Mar-06-25 10:25AM	Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently? (Insider Monkey) -5.04%
Mar-03-25 12:57PM	Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-25-25 05:56AM	Sionna Therapeutics IPO: A strategic shift in the cystic fibrosis market (Pharmaceutical Technology) -13.37%
Feb-24-25 08:00AM	Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-17-25 04:43PM	Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year? (Insider Monkey)
Feb-10-25 04:03PM	Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -11.04% -8.23%
Feb-06-25 07:51PM	Sionna Therapeutics Prices Upsized Initial Public Offering (GlobeNewswire)
03:13PM	Vertex challenger Sionna prices $191M IPO (BioPharma Dive)

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

PresidentMr. Michael Cloonan M.B.A.

Chief Financial OfficerMs. Elena H. Ridloff C.F.A.

Chief Business OfficerMs. Caroline Stark Beer M.B.A.

Co-Founder & Senior VP of Discovery ResearchDr. Greg Hurlbut Ph.D.

Co-founder & Senior VP of Medicinal ChemistryDr. Mark Munson Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thompson Peter A.	Director	May 11 '26	Sale	46.22	184,639	8,534,015	2,671,822	May 11 07:14 PM
Thompson Peter A.	Director	May 08 '26	Sale	44.58	59,767	2,664,413	2,856,461	May 11 07:14 PM
Thompson Peter A.	Director	May 07 '26	Sale	44.61	48,546	2,165,637	2,916,228	May 11 07:14 PM
ORBIMED ADVISORS LLC	Director	May 11 '26	Sale	46.22	184,639	8,534,015	2,671,822	May 11 06:58 PM
ORBIMED ADVISORS LLC	Director	May 08 '26	Sale	44.58	59,767	2,664,413	2,856,461	May 11 06:58 PM
ORBIMED ADVISORS LLC	Director	May 07 '26	Sale	44.61	48,546	2,165,637	2,916,228	May 11 06:58 PM
Thompson Peter A.	Director	Apr 17 '26	Sale	44.68	52,397	2,341,098	2,967,722	Apr 21 08:42 PM
Thompson Peter A.	Director	Apr 18 '26	Sale	44.52	2,948	131,245	2,964,774	Apr 21 08:42 PM
ORBIMED ADVISORS LLC	Director	Apr 17 '26	Sale	44.68	52,397	2,341,098	2,967,722	Apr 21 08:40 PM
ORBIMED ADVISORS LLC	Director	Apr 18 '26	Sale	44.52	2,948	131,245	2,964,774	Apr 21 08:40 PM
Thompson Peter A.	Director	Apr 15 '26	Sale	44.64	235,863	10,528,924	3,247,025	Apr 16 07:15 PM
Thompson Peter A.	Director	Apr 16 '26	Sale	45.34	226,906	10,287,918	3,020,119	Apr 16 07:15 PM
Thompson Peter A.	Director	Apr 14 '26	Sale	44.51	47,814	2,128,201	3,482,888	Apr 16 07:15 PM
ORBIMED ADVISORS LLC	Director	Apr 15 '26	Sale	44.64	235,863	10,528,924	3,247,025	Apr 16 07:03 PM
ORBIMED ADVISORS LLC	Director	Apr 16 '26	Sale	45.34	226,906	10,287,918	3,020,119	Apr 16 07:03 PM
ORBIMED ADVISORS LLC	Director	Apr 14 '26	Sale	44.51	47,814	2,128,201	3,482,888	Apr 16 07:03 PM
Fitzpatrick Jennifer	Chief Legal Officer	Mar 05 '26	Option Exercise	6.11	10,250	62,628	10,250	Mar 06 06:56 PM
Fitzpatrick Jennifer	Chief Legal Officer	Mar 05 '26	Sale	33.86	10,250	347,019	0	Mar 06 06:56 PM
JENNIFER FITZPATRICK	Officer	Mar 05 '26	Proposed Sale	34.57	10,250	354,342		Mar 05 04:28 PM
Thompson Peter A.	Director	Feb 03 '26	Sale	44.58	29,063	1,295,629	3,530,702	Feb 04 07:43 PM
Thompson Peter A.	Director	Feb 02 '26	Sale	44.57	1,890	84,237	3,559,765	Feb 04 07:43 PM
ORBIMED ADVISORS LLC	Director	Feb 03 '26	Sale	44.58	29,063	1,295,629	3,530,702	Feb 04 07:39 PM
ORBIMED ADVISORS LLC	Director	Feb 02 '26	Sale	44.57	1,890	84,237	3,559,765	Feb 04 07:39 PM
TPG GP A, LLC	10% Owner	Jan 22 '26	Sale	40.00	250,000	10,000,000	6,494,962	Jan 26 05:24 PM
Rise Fund Sling, L.P.	Stockholder	Jan 22 '26	Proposed Sale	41.77	195,667	8,173,011		Jan 22 08:47 PM
Rise Fund Sling II, L.P.	Stockholder	Jan 22 '26	Proposed Sale	41.77	54,333	2,269,489		Jan 22 08:47 PM
ORBIMED ADVISORS LLC	Director	Dec 24 '25	Sale	44.55	33,356	1,486,010	3,561,655	Dec 29 08:44 PM
Thompson Peter A.	Director	Dec 24 '25	Sale	44.55	33,356	1,486,010	3,561,655	Dec 29 08:42 PM
ORBIMED ADVISORS LLC	Director	Dec 17 '25	Sale	44.50	900	40,050	3,595,986	Dec 19 07:29 PM
ORBIMED ADVISORS LLC	Director	Dec 19 '25	Sale	44.49	875	38,929	3,595,011	Dec 19 07:29 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '25	Sale	44.49	100	4,449	3,595,886	Dec 19 07:29 PM
Thompson Peter A.	Director	Dec 17 '25	Sale	44.50	900	40,050	3,595,986	Dec 19 07:24 PM
Thompson Peter A.	Director	Dec 19 '25	Sale	44.49	875	38,929	3,595,011	Dec 19 07:24 PM
Thompson Peter A.	Director	Dec 18 '25	Sale	44.49	100	4,449	3,595,886	Dec 19 07:24 PM
Fitzpatrick Jennifer	Chief Legal Officer	Dec 05 '25	Option Exercise	6.11	10,250	62,628	10,250	Dec 09 04:57 PM
Fitzpatrick Jennifer	Chief Legal Officer	Dec 05 '25	Sale	40.52	10,250	415,330	0	Dec 09 04:57 PM
JENNIFER R FITZPATRICK	Officer	Dec 05 '25	Proposed Sale	40.88	10,250	419,020		Dec 05 04:27 PM
ORBIMED ADVISORS LLC	Director	Nov 24 '25	Sale	44.54	94,583	4,212,727	3,610,376	Nov 26 06:45 PM
ORBIMED ADVISORS LLC	Director	Nov 25 '25	Sale	44.60	11,890	530,294	3,598,486	Nov 26 06:45 PM
ORBIMED ADVISORS LLC	Director	Nov 26 '25	Sale	44.49	1,600	71,184	3,596,886	Nov 26 06:45 PM
Thompson Peter A.	Director	Nov 24 '25	Sale	44.54	94,583	4,212,727	3,610,376	Nov 26 06:41 PM
Thompson Peter A.	Director	Nov 25 '25	Sale	44.60	11,890	530,294	3,598,486	Nov 26 06:41 PM
Thompson Peter A.	Director	Nov 26 '25	Sale	44.49	1,600	71,184	3,596,886	Nov 26 06:41 PM
OrbiMed Private Investments VI	Shareholder	Nov 24 '25	Proposed Sale	44.38	1,047,770	46,500,033		Nov 24 08:22 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 21 '25	Sale	39.50	25,183	994,728	159,033	Nov 24 05:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 20 '25	Sale	40.13	5,133	205,975	166,642	Nov 24 05:43 PM
RA Capital Healthcare Fund LP	Director	Nov 21 '25	Proposed Sale	43.66	1,210	52,829		Nov 21 04:24 PM
RA Capital Nexus Fund III, L.P	Director	Nov 21 '25	Proposed Sale	43.66	6,440	281,170		Nov 21 04:21 PM
RA Capital Nexus Fund, L.P.	Director	Nov 21 '25	Proposed Sale	43.66	9,924	433,282		Nov 21 04:19 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 21 '25	Proposed Sale	43.66	7,609	332,209		Nov 21 04:17 PM
RA Capital Nexus Fund III, L.P	Director	Nov 20 '25	Proposed Sale	38.94	1,313	51,128		Nov 20 04:40 PM
RA Capital Nexus Fund, L.P.	Director	Nov 20 '25	Proposed Sale	38.94	2,023	78,776		Nov 20 04:35 PM
RA Capital Healthcare Fund LP	Director	Nov 20 '25	Proposed Sale	38.94	246	9,579		Nov 20 04:34 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 20 '25	Proposed Sale	38.94	1,551	60,396		Nov 20 04:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 17 '25	Sale	40.59	81,987	3,328,081	184,619	Nov 19 08:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 19 '25	Sale	40.01	47,442	1,898,173	168,193	Nov 19 08:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 18 '25	Sale	39.57	6,922	273,904	182,527	Nov 19 08:43 PM
RA Capital Healthcare Fund LP	Director	Nov 19 '25	Proposed Sale	39.12	2,278	89,115		Nov 19 05:21 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 19 '25	Proposed Sale	38.41	14,334	550,568		Nov 19 05:16 PM
RA Capital Nexus Fund, L.P.	Director	Nov 19 '25	Proposed Sale	38.41	18,696	718,113		Nov 19 05:10 PM
RA Capital Nexus Fund III, L.P	Director	Nov 19 '25	Proposed Sale	38.41	12,134	466,066		Nov 19 05:04 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 18 '25	Proposed Sale	39.04	2,092	81,671		Nov 18 05:22 PM
RA Capital Nexus Fund, L.P.	Director	Nov 18 '25	Proposed Sale	39.04	2,728	106,501		Nov 18 05:17 PM
RA Capital Nexus Fund III, L.P	Director	Nov 18 '25	Proposed Sale	39.04	1,770	69,100		Nov 18 05:09 PM
RA Capital Healthcare Fund LP	Director	Nov 18 '25	Proposed Sale	39.04	332	12,961		Nov 18 04:58 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 17 '25	Proposed Sale	39.93	24,772	989,146		Nov 17 05:12 PM
RA Capital Nexus Fund, L.P.	Director	Nov 17 '25	Proposed Sale	39.93	32,310	1,290,138		Nov 17 05:04 PM
RA Capital Nexus Fund III, L.P	Director	Nov 17 '25	Proposed Sale	39.93	20,969	837,292		Nov 17 04:56 PM
RA Capital Healthcare Fund LP	Director	Nov 17 '25	Proposed Sale	39.93	3,936	157,164		Nov 17 04:46 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Oct 24 '25	Sale	39.50	311,000	12,284,500	219,867	Oct 28 09:05 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Oct 28 '25	Sale	39.58	62,610	2,478,104	209,391	Oct 28 09:05 PM
RA Capital Nexus Fund III, L.P	Director	Oct 28 '25	Proposed Sale	39.45	17,118	675,305		Oct 28 05:13 PM
RA Capital Healthcare Fund LP	Director	Oct 28 '25	Proposed Sale	39.45	3,624	142,967		Oct 28 05:07 PM
RA Capital Nexus Fund, L.P.	Director	Oct 28 '25	Proposed Sale	39.45	31,392	1,238,414		Oct 28 05:05 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Oct 28 '25	Proposed Sale	39.45	10,476	413,278		Oct 28 04:57 PM
RA Capital Nexus Fund, L.P.	Director	Oct 24 '25	Proposed Sale	39.21	122,271	4,794,246		Oct 24 06:05 PM
RA Capital Nexus Fund III, L.P	Director	Oct 24 '25	Proposed Sale	39.21	66,672	2,614,209		Oct 24 06:00 PM
RA Capital Healthcare Fund LP	Director	Oct 24 '25	Proposed Sale	39.21	14,116	553,488		Oct 24 05:53 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Oct 24 '25	Proposed Sale	39.21	107,941	4,232,367		Oct 24 05:39 PM
Cloonan Michael	President & CEO	Oct 21 '25	Option Exercise	6.11	99,800	609,778	580,875	Oct 22 05:39 PM
Cloonan Michael	President & CEO	Oct 21 '25	Sale	36.26	99,800	3,618,560	547,343	Oct 22 05:39 PM
Booth Bruce	Director	Oct 21 '25	Sale	34.22	88,878	3,041,683	686,567	Oct 21 05:12 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 21 '25	Proposed Sale	32.20	15,418	496,460		Oct 21 04:22 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 21 '25	Proposed Sale	32.20	73,460	2,365,412		Oct 21 04:21 PM
MICHAEL CLOONAN	Director	Oct 21 '25	Proposed Sale	32.20	99,800	3,213,560		Oct 21 04:19 PM
Booth Bruce	Director	Oct 16 '25	Sale	32.35	169,260	5,476,168	722,301	Oct 20 09:39 PM
Booth Bruce	Director	Oct 17 '25	Sale	32.37	61,124	1,978,323	711,697	Oct 20 09:39 PM
Booth Bruce	Director	Oct 20 '25	Sale	32.09	55,985	1,796,611	701,985	Oct 20 09:39 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 20 '25	Proposed Sale	31.93	46,273	1,477,497		Oct 20 04:46 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 20 '25	Proposed Sale	31.93	9,712	310,104		Oct 20 04:46 PM
Cloonan Michael	President & CEO	Oct 15 '25	Option Exercise	6.11	14,775	90,275	562,118	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 16 '25	Option Exercise	6.11	10,425	63,697	557,568	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 15 '25	Sale	31.11	14,775	459,662	547,343	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 16 '25	Sale	31.51	10,425	328,491	547,343	Oct 17 05:11 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 17 '25	Proposed Sale	32.71	10,604	346,857		Oct 17 04:27 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 17 '25	Proposed Sale	32.72	50,520	1,653,014		Oct 17 04:27 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 16 '25	Proposed Sale	30.91	139,897	4,324,216		Oct 16 05:01 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 16 '25	Proposed Sale	30.91	29,363	907,610		Oct 16 05:00 PM
MICHAEL CLOONAN	Director	Oct 16 '25	Proposed Sale	30.91	200	6,182		Oct 16 04:34 PM
Booth Bruce	Director	Oct 15 '25	Sale	30.61	115,856	3,545,798	751,664	Oct 15 06:33 PM

Open in Screener

LTH

Life Time Group Holdings Inc

May 21 • 04:00PM ET

32.95

-0.11 -0.33 %

Consumer Cyclical • Leisure • USA • Mid • NYSE

LTH Life Time Group Holdings Inc daily Stock Chart

Peers: PLNT XPOF PTON MTN GOLF

| Held by: IJR IWM VTI VB VBK SPSM VXF AVUV IWO DFAT

Index	RUT	P/E	19.35	EPS (ttm)	1.70	Insider Own	29.29%	Shs Outstand	222.45M	Perf Week	-2.40%
Market Cap	7.33B	Forward P/E	19.09	EPS next Y	1.73	Insider Trans	-27.22%	Shs Float	157.41M	Perf Month	18.44%
Enterprise Value	11.34B	PEG	5.35	EPS next Q	0.38	Inst Own	74.79%	Short Float	7.46%	Perf Quarter	13.82%
Income	385.63M	P/S	2.38	EPS this Y	-8.85%	Inst Trans	6.95%	Short Ratio	3.54	Perf Half Y	33.40%
Sales	3.08B	P/B	2.28	EPS next Y	14.05%	ROA	5.00%	Short Interest	11.75M	Perf YTD	23.97%
Book/sh	14.47	P/C	48.84	EPS next 5Y	3.57%	ROE	12.95%	52W High	35.33 -6.74%	Perf Year	15.41%
Cash/sh	0.67	P/FCF	-	EPS past 3/5Y	- -	ROIC	5.31%	52W Low	24.14 36.50%	Perf 3Y	68.20%
Dividend Est.	-	EV/EBITDA	13.72	Sales past 3/5Y	18.01% 25.86%	Gross Margin	36.22%	Volatility	3.19% 4.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.68	EPS Y/Y TTM	73.50%	Oper. Margin	16.92%	ATR (14)	1.29	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.42	Sales Y/Y TTM	12.73%	Profit Margin	12.53%	RSI (14)	64.48	Recom	1.13
Dividend Gr. 3/5Y	- -	Current Ratio	0.53	EPS Q/Q	13.74%	SMA20	7.67%	Beta	1.53	Target Price	40.64
Payout	0.00%	Debt/Eq	1.29	Sales Q/Q	11.71%	SMA50	15.80%	Rel Volume	0.80	Prev Close	33.06
Employees	44000	LT Debt/Eq	1.26	Earnings	May 05 BMO	SMA200	19.70%	Avg Volume	3.32M	Price	32.95
IPO	Oct 07, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.20% 0.13%	Trades		Volume	2,649,431	Change	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-26	Initiated	KeyBanc Capital Markets	Overweight	$40
Mar-11-26	Initiated	Wells Fargo	Overweight	$37
Mar-10-26	Initiated	Jefferies	Buy	$40
Oct-27-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$39
Oct-17-25	Initiated	UBS	Buy	$43
May-23-25	Resumed	Craig Hallum	Buy	$45
Nov-22-24	Initiated	Evercore ISI	Outperform	$29
Jul-19-24	Initiated	Craig Hallum	Buy	$30
Apr-23-24	Initiated	Northland Capital	Outperform	$23
Oct-04-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$17
Sep-27-23	Resumed	Morgan Stanley	Equal-Weight	$18
Aug-11-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$15 → $13
Nov-01-21	Initiated	Wells Fargo	Equal Weight	$19
Nov-01-21	Initiated	RBC Capital Mkts	Outperform	$21
Nov-01-21	Initiated	Oppenheimer	Outperform	$40
Nov-01-21	Initiated	Morgan Stanley	Equal-Weight	$21
Nov-01-21	Initiated	Mizuho	Buy	$24
Nov-01-21	Initiated	Guggenheim	Buy	$21
Nov-01-21	Initiated	Goldman	Neutral	$23
Nov-01-21	Initiated	Deutsche Bank	Buy	$21

Show Previous Ratings

May-20-26 04:48PM	Is Codere Online Luxembourg (CDRO) Outperforming Other Consumer Discretionary Stocks This Year? (Quartz)
08:01AM	Life Time Launches Dynamic Nutrition Coaching, Elevating Personalized, In-Club Nutrition Guidance for Members Nationwide (PR Newswire)
May-19-26 11:40AM	Runners Pack Chicago's Lakefront for Sold-Out Life Time Chicago Spring Half Marathon & 5K (PR Newswire)
May-18-26 06:39PM	How to Help Keep Your Family Safe in the Water This Summer - Life Time Experts Share What Matters Most (PR Newswire)
May-06-26 10:45AM	Life Time Expands Running Portfolio with Acquisition of the Phoenix 10K (PR Newswire) +14.33%
07:30PM	Loading…
May-05-26 07:30PM	Life Time Announces Share Repurchase of Common Stock (PR Newswire) +11.80%
04:54PM	Life Time Group Holdings, Inc. Q1 2026 Earnings Call Summary (Moby)
06:45AM	Life Time Reports First Quarter 2026 Financial Results (PR Newswire)
May-04-26 01:01PM	Life Time Opens Ocotillo Athletic Country Club in Gilbert May 4, Capping Week of Major Phoenix-Area Expansion (PR Newswire)
09:18AM	Earnings To Watch: Life Time Group Holdings Inc (LTH) Reports Q1 2026 Result (GuruFocus.com)
Apr-30-26 08:08AM	Life Time Expands Phoenix Presence with April 30 Opening of 91,000-Square-Foot Paradise Valley Club at PV (PR Newswire)
06:45AM	Life Time Closes on $200 Million in Sale-Leaseback Transactions (PR Newswire)
Apr-29-26 07:00AM	Life Time's LT Pro 48 Pickleball Named Official Ball of Major League Pickleball; 2026 Season Kicks off in Dallas May 22 (PR Newswire)
Apr-28-26 03:54PM	Growing Together: Life Time Foundation's Enduring Commitment to a Thriving, Healthy Planet (PR Newswire)
Apr-27-26 03:02PM	Life Time Sea Otter Classic Showcases How Sport, Community and Industry Come Together (PR Newswire)
05:00AM	Loading…
Apr-24-26 05:00AM	Life Time Debuts First Athletic Country Club in Orlando Market with Opening of Life Time Winter Park on April 24 (PR Newswire)
Apr-21-26 12:14PM	Life Time Launches HYBRID XT to Fuel Rise of Hybrid Fitness Competitions, Anchored by LT Games (PR Newswire)
Apr-16-26 09:00AM	Life Time Reinforces Leadership in VO2 Max and Metabolic Testing with National Rollout of New Technology to its Athletic Country Clubs (PR Newswire)
Apr-14-26 03:19PM	Life Time to Report First Quarter 2026 Financial Results on May 5, 2026 (PR Newswire)
Apr-09-26 07:00AM	Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (PR Newswire)
Apr-08-26 07:02AM	Life Time Debuts First Luxury Athletic Country Club in Idaho, Bringing a 135,000-Square-Foot Wellness Destination to the Boise Area (PR Newswire)
Apr-01-26 09:46AM	Disney upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
Mar-24-26 11:21AM	The 60-Day Transformation Model That Works: Life Time's 60XT Challenge Returns March 30 (PR Newswire)
Mar-12-26 09:50AM	CVS upgraded, General Mills downgraded: Wall Street's top analyst calls (The Fly)
Mar-06-26 06:39PM	Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire) +6.82%
Mar-02-26 05:31PM	HIGHLIGHTS: World Gym Fireside Chat with President John Caraccio & Exec Committee Member Mark Harms (Exec Edge)
09:37AM	REPLAY: World Gym Fireside Chat with President John Caraccio & Exec Committee Member Mark Harms (Exec Edge)
Mar-01-26 03:24PM	Thousands of Runners Complete Sold-Out Life Time 305 Half Marathon & 5K (PR Newswire)
Feb-28-26 08:04AM	Life Time Group Holdings, Inc. (LTH): A Bull Case Theory (Insider Monkey)
Feb-25-26 10:06AM	World Gym Fireside Chat with President John Caraccio on Friday Feb 27 at 8AM EST (Exec Edge)
03:12AM	Loading…
03:12AM	Life Time Group Q4 Earnings Call Highlights (MarketBeat)
Feb-24-26 08:07PM	Life Time Group Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
04:03PM	Life Time Group Holdings Inc (LTH) Q4 2025 Earnings Call Highlights: Record Revenue and ... (GuruFocus.com)
09:30AM	Life Time Group Holdings (LTH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:50AM	Life Time Group Holdings, Inc. (LTH) Q4 Earnings and Revenues Top Estimates (Zacks)
07:35AM	World Gym Corp Posts 16% Surge in 2025 Profit, Declares Dividend (Exec Edge)
06:45AM	Life Time Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire)
Feb-23-26 07:18AM	What To Expect From Life Time Group Holdings Inc (LTH) Q4 2025 Earnings (GuruFocus.com)
Feb-19-26 10:00AM	Earnings Preview: Marcus (MCS) Q4 Earnings Expected to Decline (Zacks)
Feb-18-26 03:00PM	Life Time Ignites the Pilates and Reformer Boom as Demand Surges Coast to Coast (PR Newswire)
Feb-17-26 06:05PM	Caesars Entertainment (CZR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Life Time Group Holdings, Inc. (LTH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-11-26 08:00AM	Life Time Foundation Announces Move for a Life Time, the Next Chapter of its Annual Children's Health Fundraiser (PR Newswire)
Feb-10-26 01:20PM	Life Time Opens First Athletic Country Club of 2026 in West Cary - its Fourth in the Raleigh-Cary Market - Further Addressing Rapidly Growing Demand for Healthy Living (PR Newswire)
Feb-05-26 04:47PM	What Is Fibermaxxing? Life Time Experts Share Simple, Safe Ways to Add More Fiber Daily (PR Newswire)
Feb-04-26 08:00AM	Life Time to Report Fourth Quarter and Full-Year 2025 Financial Results on February 24, 2026 (PR Newswire)
Feb-02-26 02:52PM	Life Time Highlights Eight Science-Baked Heart-Health Actions during American Heart Month (PR Newswire)
Jan-25-26 08:51PM	Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners (PR Newswire)
Jan-24-26 08:50AM	Life Time Group price target raised to $42 from $41 at Northland (TipRanks)
Jan-23-26 03:47PM	Running for More than the Finish Line: Life Time Foundation Invests in Miami's Future During Marathon Weekend (PR Newswire)
Jan-22-26 06:45AM	Life Time Reports Preliminary Estimated Fourth Quarter and Full-Year 2025 Financial Results and Introduces Select Fiscal 2026 Guidance (PR Newswire)
Jan-16-26 05:11PM	Where Endurance Meets Lifestyle: Life Time Announces 2026 Athletic Events Calendar (PR Newswire)
Jan-15-26 02:30PM	Sporty, Styled Up: Category Leaders Life Time and EVEREVE Unveil Exclusive Capsule Collection Designed for Real Life; Available January 22 (PR Newswire)
Jan-05-26 08:46AM	Are Options Traders Betting on a Big Move in Life Time Group Stock? (Zacks)
Dec-31-25 07:01AM	Life Time Opens Fifth Austin Athletic Country Club on December 31, Expanding in One of America's Fastest-Growing Metros (PR Newswire)
Dec-30-25 02:02PM	2026 Life Time Wellness Survey Results Are In: Strength Training and Longevity Lead New Year Priorities with 82% Focused More on Wellbeing (PR Newswire)
Dec-26-25 11:40AM	LTH vs. ATAT: Which Stock Is the Better Value Option? (Zacks)
Dec-19-25 05:09AM	Life Time Opens Adults-Only Club in Uptown Boca on December 19; First Florida Location to Offer Coveted Athletic Reformer Class, CTR (PR Newswire)
Dec-17-25 09:40AM	Are Consumer Discretionary Stocks Lagging Life Time Group Holdings (LTH) This Year? (Zacks)
Dec-15-25 08:00AM	Life Time Opens Otay Ranch Athletic Country Club in Chula Vista, California Anchoring One of San Diego's Fastest-Growing Communities (PR Newswire)
Dec-12-25 09:55AM	Does Life Time Group Holdings (LTH) Have the Potential to Rally 54.09% as Wall Street Analysts Expect? (Zacks)
Dec-11-25 02:32PM	Life Time Reveals Top Last-Minute Gifts for the Health-Aficionados (PR Newswire)
Dec-10-25 11:40AM	LTH vs. ATAT: Which Stock Should Value Investors Buy Now? (Zacks)
Dec-04-25 03:58PM	Life Time's Hybrid Athlete Competition Returns in 2026: LT Games Presented by Ten Thousand Set for April in Minneapolis (PR Newswire)
Dec-02-25 10:02AM	Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve (Zacks)
Dec-01-25 02:25PM	LIFE TIME SIGNS LEASE AT 175 THIRD STREET, THE NEWEST DEVELOPMENT IN CHARNEY COMPANIES AND TAVROS' GOWANUS WHARF (PR Newswire)
09:40AM	Is Life Time Group Holdings (LTH) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
08:02AM	4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026 (Zacks)
Nov-27-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH) (Zacks)
Nov-26-25 09:55AM	Wall Street Analysts Predict a 46.55% Upside in Life Time Group Holdings (LTH): Here's What You Should Know (Zacks)
Nov-24-25 11:40AM	LTH or ATAT: Which Is the Better Value Stock Right Now? (Zacks)
09:11AM	Best Health & Fitness Stocks for Investors Betting on Wellness (Zacks)
Nov-21-25 09:05AM	Life Time Experts Share What to Look for in a Creatine Supplement -- Beware of Hype and Focus on Purity and Proof (PR Newswire)
Nov-13-25 09:40AM	Are Consumer Discretionary Stocks Lagging Life Time Group Holdings (LTH) This Year? (Zacks)
09:15AM	Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-12-25 12:00PM	Life Time Group Holdings (LTH) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
06:44AM	New Strong Buy Stocks for November 12th (Zacks)
Nov-11-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH) (Zacks)
08:26AM	4 Value Stocks With Strong Interest Coverage as Markets Rebound (Zacks)
Nov-07-25 11:40AM	LTH vs. ATAT: Which Stock Is the Better Value Option? (Zacks)
Nov-06-25 10:53AM	Life Time Expands CTR Reformer Workout Nationwide Amid Soaring Demand (PR Newswire)
Nov-05-25 09:55AM	How Much Upside is Left in Life Time Group Holdings (LTH)? Wall Street Analysts Think 49.85% (Zacks)
09:11AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
08:58AM	NCLH Q3 Earnings Buoyed by Record Bookings and Strong Demand (Zacks)
Nov-04-25 04:17PM	Life Time Group Holdings Inc (LTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +5.27%
11:05AM	Norwegian Q3 Earnings Beat, Revenues Miss Estimates, Stock Down (Zacks)
09:30AM	Compared to Estimates, Life Time Group Holdings (LTH) Q3 Earnings: A Look at Key Metrics (Zacks)
08:00AM	Life Time Group Holdings, Inc. (LTH) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:45AM	Life Time Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-03-25 07:24AM	Life Time Group Holdings Inc (LTH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-30-25 09:39PM	Morgan Stanley Upgrades Life Time Group Holdings (LTH) Stock to Overweight from Equal Weight (Insider Monkey)
01:59PM	It's Coming Nov. 2-Beat the Upcoming Daylight Savings Slump with These Six Expert Tips from Life Time's Chief Science Officer Jim LaValle (PR Newswire)
10:00AM	Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-28-25 01:50PM	327 Luxury Life Time Living Wellness Residences to be Part of PV Development in Phoenix, Arizona (PR Newswire)
Oct-27-25 04:05PM	Lauren Weeks and Noah Ohlsen Crowned Champions at Life Time's Inaugural LT Games Presented by Ten Thousand in Minneapolis (PR Newswire)
Oct-24-25 05:30PM	Hershey vs. Mondelez: Which candy stocks are sweet as prices rise (Yahoo Finance Video)
Oct-23-25 01:00PM	Life Time Unveils 2026 Grand Prix Series (PR Newswire)
Oct-20-25 04:38PM	Lea Jansen and Christopher Haworth Crowned Champions at Life Time's Inaugural LT Open, Each Taking Home $50,000 (PR Newswire)
Oct-17-25 05:05AM	Life Time Launches a New Era of Luxury Wellness at Iconic Prudential Center with October 17 Opening of Urban Athletic Country Club (PR Newswire)
Oct-15-25 03:15PM	Fans Invited to Experience the LT Open - Nation's First-Ever Elite Singles-Only Pickleball Tournament in Atlanta Oct. 17-19 (PR Newswire)

Life Time Group Holdings, Inc. operates as a holding company through its subsidiaries operates professional fitness, family recreation and spa centers. It is primarily engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation and spa centers in a resort-like environment, principally in residential locations of major metropolitan areas in the United States and Canada. The company was founded by Bahram Akradi in 1992 and is headquartered in Chanhassen, MN.

FounderMr. Bahram Akradi

EVP & CFOMr. Erik Weaver

Executive VP & Chief Administrative OfficerMr. Eric J. Buss

Executive VP & Chief Digital OfficerMr. R. J. Singh

President of Club OperationsMr. Parham Javaheri

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LGP Associates VI-B LLC	Stockholder	May 21 '26	Proposed Sale	32.95	49,819	1,641,536		May 21 09:57 PM
LGP Associates VI-A LLC	Stockholder	May 21 '26	Proposed Sale	32.95	4,999	164,717		May 21 09:51 PM
Green LTF Holdings II LP	Owner	May 21 '26	Proposed Sale	32.95	2,951,282	97,244,742		May 21 09:50 PM
Partners Group Private Equity	Stockholder	May 21 '26	Proposed Sale	32.95	236,468	7,791,621		May 21 09:50 PM
Partners Group Series Access I	Stockholder	May 21 '26	Proposed Sale	32.95	195,747	6,449,864		May 21 09:49 PM
Partners Group Private Equity	Stockholder	May 21 '26	Proposed Sale	32.95	520	17,134		May 21 09:49 PM
Partners Group Access 83 PF LP	Stockholder	May 21 '26	Proposed Sale	32.95	17,225	567,564		May 21 09:49 PM
TPG VII Magni Co-Invest, L.P.	Stockholder	May 21 '26	Proposed Sale	33.06	258,296	8,539,266		May 21 08:34 PM
TPG Lonestar I, L.P.	Stockholder	May 21 '26	Proposed Sale	33.06	13,060	431,764		May 21 08:32 PM
TPG VII Magni SPV, L.P.	Stockholder	May 21 '26	Proposed Sale	33.06	1,880,759	62,177,893		May 21 08:29 PM
Partners Group Private Equity	Member of 10% Owner Group	May 07 '26	Sale	31.46	747,178	23,506,220	2,431,203	May 11 09:05 PM
Green LTF Holdings II LP	Director	May 07 '26	Sale	31.46	4,991,749	157,040,424	27,009	May 11 09:01 PM
DANHAKL JOHN G	Director	May 07 '26	Sale	31.46	4,991,749	157,040,424	16,242,383	May 11 08:56 PM
Galashan John Kristofer	Director	May 07 '26	Sale	31.46	4,991,749	157,040,424	16,242,383	May 11 08:56 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	May 08 '26	Sale	31.80	62,900	2,000,226	246,574	May 11 04:28 PM
Lasher Stuart G.	Director	May 07 '26	Option Exercise	10.00	150,000	1,500,000	165,648	May 08 05:50 PM
Lasher Stuart G.	Director	May 07 '26	Sale	32.42	50,000	1,621,135	71,058	May 08 05:50 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	May 07 '26	Option Exercise	10.00	512,791	5,127,910	986,799	May 08 05:16 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	May 07 '26	Sale	32.02	192,217	6,154,423	474,008	May 08 05:16 PM
Weaver Erik	EVP & Chief Financial Officer	May 07 '26	Sale	32.69	22,000	719,202	114,166	May 08 05:15 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	May 06 '26	Sale	29.95	40,202	1,204,050	138,351	May 08 05:14 PM
Javaheri Parham	Officer	May 08 '26	Proposed Sale	31.80	62,900	2,000,228		May 08 04:09 PM
Partners Group Private Equity	Stockholder	May 07 '26	Proposed Sale	32.19	392,665	12,639,886		May 07 09:56 PM
Partners Group Access 83 PF LP	Stockholder	May 07 '26	Proposed Sale	32.19	28,604	920,763		May 07 09:55 PM
Partners Group Private Equity	Stockholder	May 07 '26	Proposed Sale	32.19	863	27,780		May 07 09:55 PM
Partners Group Series Access I	Stockholder	May 07 '26	Proposed Sale	32.19	325,046	10,463,231		May 07 09:55 PM
LGP Associates VI-A LLC	Stockholder	May 07 '26	Proposed Sale	32.19	8,301	267,209		May 07 09:41 PM
LGP Associates VI-B LLC	Stockholder	May 07 '26	Proposed Sale	32.19	82,726	2,662,950		May 07 09:39 PM
Green LTF Holdings II LP	Owner	May 07 '26	Proposed Sale	32.19	4,900,722	157,754,241		May 07 09:38 PM
TPG VII Magni SPV, L.P.	Stockholder	May 07 '26	Proposed Sale	33.59	3,123,078	104,904,190		May 07 09:11 PM
TPG VII Magni Co-Invest, L.P.	Stockholder	May 07 '26	Proposed Sale	33.59	428,911	14,407,120		May 07 09:11 PM
TPG Lonestar I, L.P.	Stockholder	May 07 '26	Proposed Sale	33.59	21,687	728,466		May 07 09:10 PM
Partners Group Private Equity	Member of 10% Owner Group	May 05 '26	Sale	28.60	542,119	15,504,603	3,178,381	May 07 07:17 PM
Galashan John Kristofer	Director	May 05 '26	Sale	28.60	2,493,083	71,302,174	22,412,978	May 07 07:10 PM
Green LTF Holdings II LP	Director	May 05 '26	Sale	28.60	2,493,083	71,302,174	37,270	May 07 07:06 PM
DANHAKL JOHN G	Director	May 05 '26	Sale	28.60	2,493,083	71,302,174	22,412,978	May 07 07:00 PM
Buss Eric J	Officer	May 07 '26	Proposed Sale	32.02	192,217	6,154,425		May 07 04:14 PM
Weaver Erik	Officer	May 07 '26	Proposed Sale	32.69	22,000	719,201		May 07 12:48 PM
Lasher Stuart G.	Director	May 07 '26	Proposed Sale	32.42	50,000	1,621,038		May 07 10:19 AM
Singh Ritadhwaja Jebens	Officer	May 06 '26	Proposed Sale	29.95	40,202	1,204,050		May 06 12:08 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	Mar 13 '26	Sale	26.46	11,060	292,648	315,175	Mar 13 05:41 PM
Javaheri Parham	Officer	Mar 13 '26	Proposed Sale	26.46	11,060	292,648		Mar 13 04:24 PM
Weaver Erik	EVP & Chief Financial Officer	Mar 03 '26	Sale	25.73	1,329	34,193	136,166	Mar 03 07:24 PM
Weaver Erik	Officer	Mar 03 '26	Proposed Sale	25.73	1,329	34,193		Mar 03 04:02 PM
Weaver Erik	EVP & Chief Financial Officer	Feb 03 '26	Sale	29.90	1,493	44,647	77,771	Feb 03 06:30 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Feb 03 '26	Sale	30.31	5,880	178,223	102,144	Feb 03 06:30 PM
Weaver Erik	Officer	Feb 03 '26	Proposed Sale	29.90	1,493	44,647		Feb 03 03:09 PM
Singh Ritadhwaja Jebens	Officer	Feb 03 '26	Proposed Sale	30.31	5,880	178,223		Feb 03 11:32 AM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jan 23 '26	Sale	29.75	12,088	359,618	110,967	Jan 27 04:36 PM
Singh Ritadhwaja Jebens	Officer	Jan 23 '26	Proposed Sale	29.75	12,088	359,618		Jan 23 04:45 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 26 '25	Option Exercise	10.00	162,722	1,627,220	543,405	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 28 '25	Option Exercise	10.00	74,487	744,870	455,170	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 26 '25	Sale	28.04	162,722	4,562,383	380,683	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 28 '25	Sale	28.05	74,487	2,089,427	380,683	Dec 01 04:33 PM
Buss Eric J	Officer	Nov 28 '25	Proposed Sale	28.05	74,487	2,089,427		Nov 28 01:34 PM
Buss Eric J	Officer	Nov 26 '25	Proposed Sale	28.04	162,722	4,562,381		Nov 26 04:13 PM
Weaver Erik	EVP & Chief Financial Officer	Oct 13 '25	Sale	25.10	4,846	121,625	81,765	Oct 14 04:32 PM
Weaver Erik	Officer	Oct 13 '25	Proposed Sale	25.10	4,846	121,627		Oct 14 07:35 AM
Partners Group Private Equity	Member of 10% Owner Group	Sep 11 '25	Sale	28.95	745,707	21,588,218	3,720,500	Sep 15 05:00 PM
DANHAKL JOHN G	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	24,906,061	Sep 15 05:00 PM
Green LTF Holdings II LP	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	41,415	Sep 15 05:00 PM
Galashan John Kristofer	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	24,906,061	Sep 15 05:00 PM
Partners Group Series Access I	Stockholder	Sep 11 '25	Proposed Sale	29.38	325,061	9,550,292		Sep 11 09:05 PM
Partners Group Access 83 PF LP	Stockholder	Sep 11 '25	Proposed Sale	29.38	27,100	796,198		Sep 11 09:02 PM
Partners Group Private Equity	Stockholder	Sep 11 '25	Proposed Sale	29.38	863	25,355		Sep 11 08:59 PM
Partners Group Private Equity	Stockholder	Sep 11 '25	Proposed Sale	29.38	392,683	11,537,027		Sep 11 08:54 PM
TPG VII Magni SPV, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	3,123,218	91,760,145		Sep 11 08:52 PM
TPG Lonestar I, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	21,688	637,193		Sep 11 08:51 PM
LGP Associates VI-B LLC	Stockholder	Sep 11 '25	Proposed Sale	29.38	82,730	2,430,607		Sep 11 08:51 PM
TPG VII Magni Co-Invest, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	428,930	12,601,963		Sep 11 08:51 PM
LGP Associates VI-A LLC	Stockholder	Sep 11 '25	Proposed Sale	29.38	8,301	243,883		Sep 11 08:48 PM
Green LTF Holdings II LP	Stockholder	Sep 11 '25	Proposed Sale	29.38	4,900,945	143,989,764		Sep 11 08:45 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	Aug 26 '25	Sale	28.05	9,375	262,933	240,151	Aug 28 04:58 PM
PARHAM JAVAHERI	Officer	Aug 26 '25	Proposed Sale	28.05	9,375	262,932		Aug 26 04:04 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	Jun 12 '25	Sale	27.84	84,744	2,359,180	249,526	Jun 16 04:28 PM
PARHAM JAVAHERI	Officer	Jun 12 '25	Proposed Sale	27.84	84,744	2,359,171		Jun 12 04:18 PM
Weaver Erik	EVP & Chief Financial Officer	Jun 06 '25	Sale	28.74	18,000	517,338	86,611	Jun 10 04:52 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jun 06 '25	Option Exercise	11.48	80,000	918,400	267,436	Jun 10 04:51 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jun 06 '25	Sale	28.80	134,247	3,866,018	133,189	Jun 10 04:51 PM
DANHAKL JOHN G	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	29,898,037	Jun 10 04:15 PM
Green LTF Holdings II LP	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	49,716	Jun 10 04:15 PM
Galashan John Kristofer	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	29,898,037	Jun 10 04:15 PM
TPG GP A, LLC	Former 10% Owner	Jun 06 '25	Sale	29.38	8,344,418	245,159,001	21,404,488	Jun 10 04:15 PM
RITADHWAJA SINGH	Officer	Jun 06 '25	Proposed Sale	28.80	134,247	3,866,013		Jun 06 04:34 PM
ERIK WEAVER	Officer	Jun 06 '25	Proposed Sale	28.74	18,000	517,331		Jun 06 04:10 PM

Open in Screener

CBLL

Ceribell Inc

May 21 • 04:00PM ET

18.74

+0.64 3.54 %

Healthcare • Medical Devices • USA • Small • NASD

Peers: NPCE CLPT EDAP IRMD ATEC

| Held by: VTI IWM VXF IWO VTWO FFSM SCHA LFSC IWC VHT

Index	RUT	P/E	-	EPS (ttm)	-1.63	Insider Own	35.28%	Shs Outstand	37.86M	Perf Week	13.85%
Market Cap	711.05M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	-4.31%	Shs Float	24.56M	Perf Month	-12.14%
Enterprise Value	591.99M	PEG	-	EPS next Q	-0.47	Inst Own	66.19%	Short Float	7.67%	Perf Quarter	-7.32%
Income	-60.37M	P/S	7.48	EPS this Y	-16.92%	Inst Trans	4.10%	Short Ratio	5.97	Perf Half Y	41.97%
Sales	95.07M	P/B	5.04	EPS next Y	32.83%	ROA	-30.84%	Short Interest	1.88M	Perf YTD	-14.55%
Book/sh	3.72	P/C	5.04	EPS next 5Y	16.80%	ROE	-37.53%	52W High	24.33 -22.98%	Perf Year	6.78%
Cash/sh	3.72	P/FCF	-	EPS past 3/5Y	-10.19% -	ROIC	-37.32%	52W Low	10.85 72.72%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	50.90% -	Gross Margin	87.72%	Volatility	4.96% 5.45%	Perf 5Y	-
Dividend TTM	-	EV/Sales	6.23	EPS Y/Y TTM	-	Oper. Margin	-68.31%	ATR (14)	1.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.87	Sales Y/Y TTM	-	Profit Margin	-63.51%	RSI (14)	49.51	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.30	EPS Q/Q	-47.15%	SMA20	-1.95%	Beta	0.93	Target Price	26.86
Payout	-	Debt/Eq	0.16	Sales Q/Q	29.30%	SMA50	-2.12%	Rel Volume	1.81	Prev Close	18.10
Employees	327	LT Debt/Eq	0.15	Earnings	May 11 AMC	SMA200	10.91%	Avg Volume	315.44K	Price	18.74
IPO	Oct 11, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-33.06% 1.57%	Trades		Volume	563,638	Change	3.54%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Initiated	Raymond James	Strong Buy	$19
Jun-24-25	Initiated	BTIG Research	Buy	$30
Apr-04-25	Initiated	Ladenburg Thalmann	Buy	$32
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	TD Cowen	Buy	$31
Nov-05-24	Initiated	JP Morgan	Overweight	$32
Nov-05-24	Initiated	Canaccord Genuity	Buy	$30
Nov-05-24	Initiated	BofA Securities	Buy	$32

May-20-26 04:05PM	Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +6.72%
May-12-26 03:07AM	CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ... (GuruFocus.com) -16.50%
May-11-26 04:05PM	Ceribell Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-08-26 09:17AM	What To Expect From CeriBell Inc (CBLL) Q1 2026 Earnings (GuruFocus.com)
Apr-29-26 04:05PM	Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference (GlobeNewswire) -7.45%
04:05PM	Loading…
Apr-20-26 04:05PM	Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 (GlobeNewswire)
Mar-07-26 11:15AM	CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium (MarketBeat)
10:23AM	CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot (MarketBeat)
Mar-02-26 10:23AM	Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord (Insider Monkey)
Feb-25-26 12:03AM	CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... (GuruFocus.com)
Feb-24-26 10:06PM	CeriBell Q4 Earnings Call Highlights (MarketBeat)
09:55PM	CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
08:03PM	CeriBell, Inc. Q4 2025 Earnings Call Summary (Moby)
04:05PM	Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-23-26 07:26AM	CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
04:05PM	Loading…
Feb-18-26 04:05PM	Ceribell to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-10-26 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
Jan-14-26 09:21AM	CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion (MarketBeat)
Jan-06-26 12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
Jan-05-26 08:00AM	Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution (GlobeNewswire)
Dec-30-25 04:05PM	Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire)
Dec-09-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution (GlobeNewswire)
Nov-24-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates (GlobeNewswire)
Nov-19-25 04:05PM	Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-25 12:06AM	CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +7.88%
Nov-04-25 06:05PM	CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Third Quarter 2025 Financial Results (GlobeNewswire)
10:00AM	Loading…
Oct-29-25 10:00AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.24%
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-21-25 04:05PM	Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire) +7.04%
Sep-22-25 08:00AM	Medtech Leader Erica Rogers Joins Ceribell Board of Directors (GlobeNewswire)
Aug-13-25 12:08PM	J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT (Insider Monkey)
Aug-05-25 04:05PM	Ceribell Reports Second Quarter 2025 Financial Results (GlobeNewswire) -15.25%
Jul-29-25 04:05PM	Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-22-25 04:05PM	Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-07-25 04:42PM	Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware (GlobeNewswire) -9.14%
Jun-20-25 09:11AM	AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape (PR Newswire)
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive)
May-20-25 04:05PM	Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:43AM	CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com) -6.61%
May-08-25 04:05PM	Ceribell Reports First Quarter 2025 Financial Results (GlobeNewswire) +6.81%
Apr-30-25 04:05PM	Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
08:00AM	Ceribell Receives FedRAMP High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems (GlobeNewswire)
Apr-24-25 04:05PM	Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 05:00AM	Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
Apr-16-25 10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
Apr-15-25 08:00AM	FDA Clears Ceribell's Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older (GlobeNewswire)
Apr-07-25 01:04PM	CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It Today (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Feb-26-25 02:15AM	CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com)
Feb-25-25 04:05PM	Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference (GlobeNewswire)
Feb-11-25 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (GlobeNewswire)
Dec-23-24 04:05PM	Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-19-24 08:00AM	Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing (GlobeNewswire)
07:01AM	Meet the biophysicist whose seizure-detection company is using AI to get a better read on peoples brains (FastCompany)
Nov-13-24 11:55PM	Ceribell, Inc. Reports Strong Q3 2024 Growth (TipRanks)
Nov-12-24 04:05PM	Ceribell Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs (GlobeNewswire)
Nov-07-24 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-06-24 06:31AM	Ceribell initiated with a Buy at BofA on differentiated AI algorithm (TipRanks)
Oct-29-24 04:05PM	Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 (PR Newswire)
Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Co-FounderDr. Xingjuan Chao Ph.D.

Ph.D.Dr. Josef Parvizi M.D.

Chief Financial OfficerMr. Scott Blumberg

Chief Technology OfficerDr. Raymond Woo Ph.D.

Senior Vice President of OperationsMr. Dan Rogy

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Foehr David	Officer	May 21 '26	Proposed Sale	18.00	987	17,762		May 21 04:10 PM
Woo Raymond	Officer	May 21 '26	Proposed Sale	18.00	1,966	35,380		May 21 04:04 PM
Chao Xingjuan	Officer	May 21 '26	Proposed Sale	18.00	6,030	108,515		May 21 03:53 PM
Manni Joseph S.	Officer	May 21 '26	Proposed Sale	18.00	1,378	24,798		May 21 03:51 PM
Blumberg Scott	Officer	May 21 '26	Proposed Sale	18.00	1,387	24,960		May 21 03:15 PM
BURKE WILLIAM W	Director	May 08 '26	Proposed Sale	26.01	4,823	125,446		May 08 10:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Option Exercise	4.70	25,000	117,500	859,901	May 07 11:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Sale	20.10	39,000	783,973	836,347	May 07 11:09 AM
Chao Xingjuan	Officer	May 05 '26	Proposed Sale	20.10	39,000	784,000		May 05 04:25 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Option Exercise	4.37	11,104	48,575	204,259	May 04 07:05 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Sale	20.44	11,104	226,928	197,648	May 04 07:05 PM
Woo Raymond	Officer	May 01 '26	Proposed Sale	20.16	11,104	223,857		May 01 03:10 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Option Exercise	4.70	25,000	117,500	873,901	Apr 08 12:47 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Sale	18.40	39,000	717,600	850,347	Apr 08 12:47 PM
Chao Xingjuan	Officer	Apr 06 '26	Proposed Sale	18.40	39,000	717,551		Apr 06 04:27 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Option Exercise	4.37	11,112	48,605	173,527	Apr 03 01:55 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Sale	18.56	11,112	206,244	166,912	Apr 03 01:55 PM
Woo Raymond	Officer	Apr 01 '26	Proposed Sale	18.56	11,112	206,261		Apr 01 04:21 PM
Chao Xingjuan	President and CEO	Mar 25 '26	Option Exercise	2.72	55,628	151,397	766,792	Mar 27 12:25 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Option Exercise	4.70	4,560	21,432	20,953	Mar 05 02:22 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Sale	17.80	4,560	81,168	17,550	Mar 05 02:22 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Sale	17.80	827	14,721	18,749	Mar 05 02:20 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Option Exercise	4.70	25,000	117,500	734,718	Mar 05 02:18 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Sale	17.45	39,000	680,564	711,164	Mar 05 02:18 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Option Exercise	4.37	11,112	48,605	173,527	Mar 04 01:28 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Sale	18.25	8,087	147,602	166,912	Mar 04 01:28 PM
Chao Xingjuan	Officer	Mar 03 '26	Proposed Sale	17.80	39,000	694,200		Mar 03 01:46 PM
Foehr David	Officer	Mar 03 '26	Proposed Sale	17.80	4,560	81,168		Mar 03 12:17 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Proposed Sale	17.80	827	14,721		Mar 03 11:37 AM
Woo Raymond	Officer	Mar 02 '26	Proposed Sale	18.14	11,112	201,572		Mar 02 11:56 AM
Foehr David	Senior VP, Finance and PAO	Feb 24 '26	Sale	19.98	781	15,604	17,550	Feb 25 04:46 PM
Foehr David	Senior VP, Finance and PAO	Feb 23 '26	Sale	19.79	569	11,261	18,331	Feb 25 04:46 PM
Manni Joseph S.	Chief Revenue Officer	Feb 23 '26	Sale	19.79	768	15,199	26,933	Feb 25 04:46 PM
Woo Raymond	Chief Technology Officer	Feb 23 '26	Sale	19.79	705	13,952	166,912	Feb 25 04:45 PM
Blumberg Scott	Chief Financial Officer	Feb 23 '26	Sale	19.79	808	15,990	118,334	Feb 25 04:45 PM
Chao Xingjuan	President and CEO	Feb 23 '26	Sale	19.79	2,084	41,242	725,164	Feb 25 04:44 PM
Foehr David	Officer	Feb 24 '26	Proposed Sale	19.98	781	15,604		Feb 24 11:35 AM
Woo Raymond	Officer	Feb 23 '26	Proposed Sale	19.79	705	13,955		Feb 23 04:46 PM
Chao Xingjuan	Officer	Feb 23 '26	Proposed Sale	19.79	2,084	41,252		Feb 23 04:45 PM
Manni Joseph S.	Officer	Feb 23 '26	Proposed Sale	19.79	768	15,202		Feb 23 04:36 PM
Blumberg Scott	Officer	Feb 23 '26	Proposed Sale	19.79	808	15,994		Feb 23 04:34 PM
Foehr David	Officer	Feb 23 '26	Proposed Sale	19.79	569	11,263		Feb 23 04:26 PM
Parvizi Josef	Director	Feb 19 '26	Sale	20.27	16,714	338,793	722,652	Feb 23 12:07 PM
Parvizi Josef	Director	Feb 18 '26	Sale	20.00	6,986	139,720	739,366	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 17 '26	Sale	20.00	1,300	26,000	746,352	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 19 '26	Proposed Sale	20.27	16,714	338,754		Feb 19 04:08 PM
Parvizi Josef	Director	Feb 18 '26	Proposed Sale	20.01	6,986	139,770		Feb 18 04:20 PM
Parvizi Josef	Director	Feb 17 '26	Proposed Sale	20.00	1,300	26,000		Feb 17 04:37 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Option Exercise	4.70	25,000	117,500	750,802	Feb 06 03:51 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Sale	20.16	39,000	786,240	727,248	Feb 06 03:51 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Option Exercise	4.70	5,556	26,113	22,303	Feb 05 12:54 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Sale	20.00	5,556	111,120	18,900	Feb 05 12:54 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Option Exercise	4.37	11,112	48,605	174,232	Feb 04 04:01 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Sale	20.55	11,112	228,375	167,617	Feb 04 04:01 PM
Chao Xingjuan	Officer	Feb 04 '26	Proposed Sale	20.51	39,000	799,890		Feb 04 02:38 PM
Foehr David	Officer	Feb 03 '26	Proposed Sale	20.00	5,556	111,120		Feb 03 10:35 AM
Woo Raymond	Officer	Feb 02 '26	Proposed Sale	20.80	11,112	231,130		Feb 02 03:24 PM
Parvizi Josef	Director	Jan 15 '26	Sale	22.94	25,000	573,500	747,652	Jan 20 04:52 PM
Parvizi Josef	Director	Jan 15 '26	Proposed Sale	22.94	25,000	573,453		Jan 15 04:24 PM
Foehr David	Senior VP, Finance and PAO	Jan 05 '26	Option Exercise	4.70	5,556	26,113	22,303	Jan 07 07:12 PM
Foehr David	Senior VP, Finance and PAO	Jan 05 '26	Sale	22.60	5,556	125,566	18,900	Jan 07 07:12 PM
Chao Xingjuan	President and CEO	Jan 05 '26	Option Exercise	4.70	25,000	117,500	764,802	Jan 07 06:09 PM
Chao Xingjuan	President and CEO	Jan 05 '26	Sale	21.27	79,000	1,680,048	741,248	Jan 07 06:09 PM
Woo Raymond	Chief Technology Officer	Jan 02 '26	Option Exercise	4.37	11,112	48,605	173,932	Jan 06 05:16 PM
Woo Raymond	Chief Technology Officer	Jan 02 '26	Sale	21.18	11,112	235,382	167,317	Jan 06 05:16 PM
ROBERTSON REBECCA B	Director	Jan 02 '26	Option Exercise	2.24	2,500	5,600	22,076	Jan 06 05:16 PM
ROBERTSON REBECCA B	Director	Jan 02 '26	Sale	21.89	2,500	54,725	19,576	Jan 06 05:16 PM
Chao Xingjuan	Officer	Jan 05 '26	Proposed Sale	21.27	79,000	1,680,125		Jan 05 04:46 PM
Foehr David	Officer	Jan 05 '26	Proposed Sale	22.60	5,556	125,566		Jan 05 11:02 AM
ROBERTSON REBECCA B	Director	Jan 02 '26	Proposed Sale	21.89	2,500	54,725		Jan 02 11:21 AM
Woo Raymond	Officer	Jan 02 '26	Proposed Sale	21.89	11,112	243,242		Jan 02 10:52 AM
Blumberg Scott	Chief Financial Officer	Dec 22 '25	Option Exercise	4.23	36,000	152,105	138,561	Dec 29 01:40 PM
Blumberg Scott	Chief Financial Officer	Dec 22 '25	Sale	21.00	36,000	756,000	118,842	Dec 29 01:40 PM
Blumberg Scott	Officer	Dec 22 '25	Proposed Sale	21.00	36,000	756,000		Dec 22 10:01 AM
Parvizi Josef	Director	Dec 15 '25	Sale	21.49	25,000	537,250	772,652	Dec 17 08:07 PM
Parvizi Josef	Director	Dec 15 '25	Proposed Sale	21.55	25,000	538,650		Dec 15 04:34 PM
BURKE WILLIAM W	Director	Dec 09 '25	Option Exercise	3.97	32,728	130,085	40,391	Dec 11 04:48 PM
BURKE WILLIAM W	Director	Dec 09 '25	Sale	22.02	32,728	720,671	17,391	Dec 11 04:48 PM
Parvizi Josef	Director	Dec 08 '25	Sale	20.26	25,000	506,500	797,652	Dec 10 08:00 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Option Exercise	2.24	5,000	11,200	13,388	Dec 10 01:02 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Sale	20.00	5,000	100,000	8,388	Dec 10 01:02 PM
BURKE WILLIAM W	Director	Dec 09 '25	Proposed Sale	22.02	32,728	720,688		Dec 09 04:05 PM
Parvizi Josef	Director	Dec 08 '25	Proposed Sale	20.26	25,000	506,467		Dec 08 04:28 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Option Exercise	2.24	25,000	56,000	823,135	Dec 08 01:01 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Sale	18.82	25,000	470,500	798,135	Dec 08 01:01 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Proposed Sale	20.00	5,000	100,000		Dec 08 12:27 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Option Exercise	4.70	4,399	20,675	21,630	Dec 05 05:35 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Sale	16.83	5,265	88,610	19,384	Dec 05 05:35 PM
Chao Xingjuan	Officer	Dec 04 '25	Proposed Sale	18.82	25,000	470,534		Dec 04 04:44 PM
ROBERTSON REBECCA B	Director	Dec 02 '25	Sale	16.67	827	13,786	8,388	Dec 04 02:16 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Option Exercise	4.37	11,112	48,605	178,816	Dec 03 01:34 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Sale	12.28	11,112	136,455	167,704	Dec 03 01:34 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Option Exercise	3.65	25,000	91,250	823,135	Dec 03 01:33 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Sale	16.59	25,000	414,750	798,135	Dec 03 01:33 PM
Foehr David	Officer	Dec 03 '25	Proposed Sale	16.83	5,265	88,610		Dec 03 10:06 AM
ROBERTSON REBECCA B	Director	Dec 02 '25	Proposed Sale	16.67	827	13,786		Dec 02 09:50 AM
Chao Xingjuan	Officer	Dec 01 '25	Proposed Sale	16.87	25,000	421,750		Dec 01 12:20 PM
Woo Raymond	Officer	Dec 01 '25	Proposed Sale	16.87	11,112	187,459		Dec 01 10:17 AM
Chao Xingjuan	President and CEO	Nov 21 '25	Option Exercise	2.94	50,000	147,250	848,135	Nov 25 06:39 PM
Chao Xingjuan	President and CEO	Nov 21 '25	Sale	15.13	50,000	756,500	798,135	Nov 25 06:39 PM

Open in Screener

CWK

Cushman & Wakefield Ltd

May 21 • 04:00PM ET

12.82

-0.04 -0.31 %

Real Estate • Real Estate Services • Bermuda • Mid • NYSE

CWK Cushman & Wakefield Ltd daily Stock Chart

Peers: CIGI NMRK JLL CBRE AGNT

| Held by: VNQ IJR VTI VB VBR IWM VXF SPSM IJS FESM

Index	RUT	P/E	40.88	EPS (ttm)	0.31	Insider Own	0.71%	Shs Outstand	234.29M	Perf Week	0.00%
Market Cap	3.00B	Forward P/E	7.52	EPS next Y	1.70	Insider Trans	-1.19%	Shs Float	232.63M	Perf Month	-11.83%
Enterprise Value	5.50B	PEG	0.10	EPS next Q	0.34	Inst Own	91.44%	Short Float	3.29%	Perf Quarter	-3.83%
Income	73.70M	P/S	0.29	EPS this Y	320.28%	Inst Trans	3.03%	Short Ratio	4.47	Perf Half Y	-13.32%
Sales	10.54B	P/B	1.54	EPS next Y	17.25%	ROA	0.98%	Short Interest	7.65M	Perf YTD	-20.82%
Book/sh	8.33	P/C	4.85	EPS next 5Y	77.86%	ROE	3.95%	52W High	17.40 -26.32%	Perf Year	34.66%
Cash/sh	2.64	P/FCF	24.64	EPS past 3/5Y	-24.16% -	ROIC	1.49%	52W Low	9.43 35.95%	Perf 3Y	63.10%
Dividend Est.	-	EV/EBITDA	10.15	Sales past 3/5Y	0.60% 5.58%	Gross Margin	16.84%	Volatility	5.10% 4.35%	Perf 5Y	-30.93%
Dividend TTM	-	EV/Sales	0.52	EPS Y/Y TTM	-54.85%	Oper. Margin	3.80%	ATR (14)	0.61	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.13	Sales Y/Y TTM	10.40%	Profit Margin	0.70%	RSI (14)	41.38	Recom	1.83
Dividend Gr. 3/5Y	- -	Current Ratio	1.13	EPS Q/Q	-759.76%	SMA20	-5.93%	Beta	1.49	Target Price	17.90
Payout	0.00%	Debt/Eq	1.60	Sales Q/Q	11.00%	SMA50	-3.01%	Rel Volume	1.79	Prev Close	12.86
Employees	53000	LT Debt/Eq	1.53	Earnings	May 07 BMO	SMA200	-14.20%	Avg Volume	1.71M	Price	12.82
IPO	Aug 02, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-90.71% 64.45%	Trades		Volume	3,031,705	Change	-0.31%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$19
Dec-02-25	Initiated	Barclays	Equal Weight	$18
Nov-21-25	Upgrade	Citigroup	Neutral → Buy	$18
Aug-08-25	Upgrade	Goldman	Sell → Buy	$17.50
Jul-21-25	Initiated	Citizens JMP	Mkt Outperform	$15
Jan-02-25	Downgrade	Jefferies	Buy → Hold	$18 → $14
Dec-06-24	Initiated	Goldman	Sell	$15
Apr-10-24	Initiated	Jefferies	Buy	$13
Apr-09-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-03-24	Downgrade	Raymond James	Strong Buy → Outperform	$13
Dec-08-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$12
Apr-17-23	Downgrade	UBS	Buy → Neutral	$19 → $10
Apr-10-23	Downgrade	Goldman	Buy → Neutral	$15.50 → $11
Feb-01-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-05-22	Initiated	Goldman	Buy	$25
Nov-22-21	Upgrade	Raymond James	Outperform → Strong Buy	$31
Jun-15-21	Initiated	Wolfe Research	Outperform	$27
May-17-21	Downgrade	BofA Securities	Neutral → Underperform	$16.50
Jan-25-21	Initiated	Goldman	Neutral	$15.50
Sep-17-20	Initiated	Raymond James	Outperform	$18

Show Previous Ratings

May-21-26 02:46PM	Cushman & Wakefield Arranges $74.1 Million Financing for Bank of Italy Office-to-Residential Conversion in Downtown San Jose (Business Wire)
May-20-26 09:00AM	Dallas, Texas Ranked No. 1 Primary Data Market in the World as AI Demand, Power Constraints and Regulation Reshape CRE Strategy (Business Wire)
May-19-26 01:00PM	Aracibo Quintana and Marty Arrivo Join Cushman & Wakefield to Expand South Florida Retail Platform (Business Wire)
May-15-26 11:38AM	Cushman & Wakefield Appointed as Valuer of SEGROs UK Portfolio (Business Wire)
May-12-26 11:28AM	Cushman & Wakefield Appoints Jonathan ORegan as Head of West End Capital Markets (Business Wire)
09:00AM	Loading…
May-08-26 09:00AM	Cushman & Wakefield Report: AI to Add 330 Million Square Feet of CRE Demand Over Next Decade (Business Wire)
May-07-26 12:50PM	Cushman & Wakefield plc Q1 2026 Earnings Call Summary (Moby)
07:00AM	Cushman & Wakefield Reports Financial Results for the First Quarter 2026 (Business Wire)
May-06-26 12:03PM	Ryan Miller Expands Role to Oversee Atlanta and Nashville Markets (Business Wire)
Apr-29-26 04:24PM	Cushman & Wakefield Hires Tom Maloney as Chair of Occupier Advisory Services (Business Wire)
Apr-20-26 04:49PM	U.S. Office Market Stabilizes as Demand Concentrates in Leading Markets and Supply Continues to Contract (Business Wire)
Apr-16-26 02:11PM	Cushman & Wakefield Hires Dr. Miguel A. Rodriguez as Head of Data Science & Geospatial Analytics (Business Wire)
Apr-14-26 02:12PM	Cushman & Wakefield Market Report: Peak Industrial Vacancy Likely in Rearview Mirror as Demand Holds and Supply Slows (Business Wire)
Apr-13-26 04:30PM	Cushman & Wakefield to Release First Quarter 2026 Earnings on May 7 (Business Wire)
Apr-08-26 10:02AM	Cushman & Wakefield Markets Iconic Domino Sugar Refinery Site in New York City (Business Wire) +6.61%
11:54AM	Loading…
Apr-02-26 11:54AM	Cushman & Wakefield Announces Two Senior Hires in New Jersey to Strengthen Global Portfolio Solutions Offering (Business Wire)
Mar-31-26 01:43PM	Cushman & Wakefield Recognized by Newsweek as One of America's Greatest Workplaces for Women (Business Wire)
Mar-23-26 01:00PM	Luxury and Contemporary Brands Are Competing for Prime Retail Space Across Europe (WWD)
09:22AM	Luxury Store Openings in Europe Rise 13% Despite Demand Slowdown (GuruFocus.com)
Mar-20-26 10:40AM	CA Sri Lanka introduces new business law and compliance faculty (The Accountant)
Mar-19-26 04:02AM	Rahway project lands $56M loan for 277,000-square-foot warehouse (Home News Tribune \| My Central Jersey)
Mar-16-26 09:00AM	Victoria Lake Joins Cushman & Wakefield as Chief Financial Officer, APAC & EMEA (Business Wire)
Mar-13-26 03:38PM	Cushman & Wakefield Recognized by Forbes as One of Americas Best Employers for Company Culture (Business Wire)
Mar-11-26 10:00AM	Cushman & Wakefield Research Shows Large Warehouse Deals Roar Back as Big-Box Leasing Rebounds Across U.S. (Business Wire)
Mar-09-26 02:14PM	Cushman & Wakefield Arranges $72M Acquisition Financing for Seven-Asset Industrial Portfolio in Maryland (Business Wire)
Mar-06-26 02:15PM	Cushman & Wakefield Named No. 2 Top Real Estate Brand (Business Wire)
Mar-05-26 04:25PM	Your 401(k) could shrink due to climate risks. A lawsuit argues that your employer has a duty to protect it (FastCompany)
07:39AM	Real estate firm hit with class-action lawsuit over climate risk in retirement plan (ESG Dive)
Mar-04-26 07:00AM	How commercial property management firms are using AI and hope to use it tomorrow (Facilities Dive)
Mar-03-26 10:03AM	Cushman & Wakefield Recruits NAI Southcoast and JSA Teams in Florida (Business Wire)
11:03PM	Loading…
Mar-02-26 11:03PM	Cushman & Wakefield (CWK): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-01-26 11:36PM	3 Reasons CWK is Risky and 1 Stock to Buy Instead (StockStory)
Feb-26-26 09:15AM	International Markets and Cushman & Wakefield (CWK): A Deep Dive for Investors (Zacks)
12:34AM	The Top 5 Analyst Questions From Cushman & Wakefield's Q4 Earnings Call (StockStory)
Feb-25-26 12:33PM	5 industries that have gotten rocked by the AI 'scare trade' defining markets this year (Yahoo Finance)
Feb-23-26 10:12AM	Cushman & Wakefield Named to IAOP Global 100 List for 15th Consecutive Year (Business Wire)
05:30AM	AI Anxiety Has Found Its Way to Real-Estate Brokers (The Wall Street Journal)
Feb-21-26 08:43AM	Cushman & Wakefield (CWK) Delivers Record Revenue as Commercial Real Estate Demand Holds Firm (Insider Monkey)
Feb-20-26 11:00AM	Cushman & Wakefield Q4 Earnings Call Highlights (MarketBeat)
09:00AM	Cushman & Wakefield Launches Commercial Real Estates First Model Designed to Quantify AI Momentum Across the Built Environment (Business Wire)
06:04AM	Services help drive Cushman & Wakefield Q4 revenue up by 11% (Facilities Dive)
12:34AM	CWK Q4 Deep Dive: Capital Markets Growth, AI Adoption, and Operating Leverage Priorities (StockStory)
Feb-19-26 02:15PM	Analyst Report: Cushman & Wakefield Limited (Morningstar Research)
12:32PM	Cushman & Wakefield plc Q4 2025 Earnings Call Summary (Moby)
11:00AM	Cushman & Wakefield (CWK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Cushman & Wakefield (CWK) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:23AM	Cushman & Wakefield's (NYSE:CWK) Q4 CY2025 Sales Beat Estimates (StockStory)
07:20AM	Cushman & Wakefield: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Cushman & Wakefield Reports Financial Results for the Fourth Quarter and Full Year 2025 (Business Wire)
06:10AM	Cushman & Wakefield (CWK) Rebounds 10% on Q4, FY Earnings Blowout (Insider Monkey)
Feb-17-26 10:01PM	Cushman & Wakefield (CWK) Q4 Earnings Report Preview: What To Look For (StockStory) +9.98%
09:15AM	Unlocking Q4 Potential of Cushman & Wakefield (CWK): Exploring Wall Street Estimates for Key Metrics (Zacks)
Feb-15-26 11:38PM	3 Cash-Producing Stocks That Concern Us (StockStory)
11:32AM	AI Disruption Fears Slam Real Estate Brokers (Benzinga)
Feb-13-26 04:21PM	Wolfe Research Upgrades Cushman & Wakefield Limited (CWK) to Outperform and Sets a $19 Price Target (Insider Monkey)
10:44AM	From software to real estate, U.S. sectors under the grip of AI scare trade (Reuters)
10:39AM	Bryan Doyle Joins Cushman & Wakefield as Chief Operating Officer, Americas Capital Markets (Business Wire)
Feb-12-26 04:57PM	AI Disruption Fears Slam Real Estate Brokers (Benzinga) -11.52%
04:35PM	AI Jitters Spread to Commercial Real Estate (The Wall Street Journal)
04:26PM	Real Estate Stocks Sink as Worries About AI Risks Spread (Bloomberg)
12:40PM	Property sector hit as investors bet AI can replace estate agents (The Telegraph)
12:13PM	CBRE Group Q4 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
11:51AM	Gabrielle Harvey and Brendan Callahan Join Cushman & Wakefield As Executive Vice Chairs in New England (Business Wire)
11:04AM	Renaissance Loads Up on Netflix, Lam Research, ServiceNow - Smart Money Signals Shift (Benzinga)
10:00AM	Cushman & Wakefield (CWK) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	AI Disruption Hit Multiple Sector ETFs: Is the Fear Overblown? (Zacks)
06:24AM	Stocks Rise Before the Open on U.S. Economic Optimism, Earnings and Jobless Claims Data in Focus (Barchart)
Feb-11-26 06:20PM	Analyst Report: Cushman & Wakefield Limited (Morningstar Research) -13.82%
04:28PM	Cushman & Wakefield leads 14% real estate stock slide on AI fears (Investing.com)
04:26PM	Real Estate Services Stocks Sink in Latest AI Scare Trade (Bloomberg)
10:30AM	Federal Realty to Report Q4 Earnings: What to Expect From the Stock? (Zacks)
Feb-10-26 03:00PM	Cushman & Wakefield Hires Kevin Donner as Vice Chair in Los Angeles (Business Wire)
10:40AM	What's in the Cards for Kimco Realty Stock in Q4 Earnings? (Zacks)
Feb-08-26 10:00AM	Here Is Why Hedge Funds Favor Cushman & Wakefield (CWK) (Insider Monkey)
Feb-05-26 03:08PM	Cushman & Wakefield Hires Damla Gerhart as Executive Regional Director, Midwest Region (Business Wire)
Feb-04-26 10:21AM	Regency Centers to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-02-26 10:00AM	Cushman & Wakefield Announces New Leadership for National Industrial Advisory Group (Business Wire)
Jan-30-26 01:01PM	Gregg Metcalf Joins Cushman & Wakefield as Executive Director (Business Wire)
Jan-29-26 11:02PM	Cushman & Wakefield (CWK): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
10:35AM	What to Expect From Simon Property Stock This Earnings Season? (Zacks)
Jan-28-26 02:51AM	The Zacks Analyst Blog Cushman & Wakefield's, Simon Property, Regency Centers, Kimco and Federal Realty Investment (Zacks)
Jan-22-26 11:55AM	Are Industrial REITs Poised to Grow Amid Recovery in Demand? (Zacks)
09:00AM	Cushman & Wakefield Hires Joey Verrant as Chief Operating Officer of Asset Services Multifamily (Business Wire)
Jan-21-26 09:00AM	Cushman & Wakefield to Release Fourth Quarter and Full Year 2025 Earnings on February 19 (Business Wire)
Jan-15-26 04:10PM	Cushman & Wakefield Expands Occupier Advisory Capabilities with Top Industrial Brokers Joe Howell and Brett Spitzer (Business Wire)
Jan-14-26 10:35PM	Q3 Earnings Outperformers: Cushman & Wakefield (NYSE:CWK) And The Rest Of The Real Estate Services Stocks (StockStory)
09:15AM	Cushman & Wakefield price target raised to $19 from $18 at Barclays (TipRanks)
Jan-05-26 03:00PM	Cushman & Wakefield Hires Andy Jansen as President of Project & Development Services (Business Wire) +5.62%
Dec-30-25 07:40AM	He retired at 34 with $3 million, then had to go back to work after buying a house. How to avoid his mistake (Moneywise)
Dec-10-25 04:30AM	Hong Kong home prices to rise in 2026 on the back of mainland Chinese buyers, rate cut (South China Morning Post)
Dec-04-25 02:30PM	Cushman & Wakefield Forecasts U.S. CRE Market Shift From Resilience to Optimism in 2026 (Business Wire)
Dec-03-25 10:00AM	Cushman & Wakefield Secures Global Contract Extension with BHP (Business Wire)
Nov-28-25 08:02AM	Cushman & Wakefield Completes Redomiciliation to Bermuda (Business Wire)
Nov-24-25 11:41AM	Cushman & Wakefield Expands Retail Expertise with Appointments of Jessica Gangoso and Kristen Pash (Business Wire)
Nov-21-25 05:16PM	Why Is Cushman & Wakefield (CWK) Stock Rocketing Higher Today (StockStory) +8.62%
09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
Nov-18-25 05:31PM	Analyst Report: Cushman & Wakefield plc (Morningstar Research)
Nov-17-25 04:55AM	Investors return to German hotels, but risks remain (Hotel Management Network)
Nov-11-25 11:00AM	Cushman & Wakefield Earns 2026 Military Friendly Employer Designation, Expands Veteran Initiatives Nationwide (Business Wire)
Nov-10-25 11:59PM	REMAX Canada Strengthens Commercial Division with Appointment of Damon Conrad as Vice President (Albuquerque Journal, N.M.)

Cushman & Wakefield Ltd. s a global commercial real estate services firm for property owners. The company is headquartered in Hamilton, Bermuda.

Global CEO & DirectorMs. Michelle Marie MacKay

Global President & COOMr. Andrew McDonald

Executive VP & Global CFOMr. Neil O. Johnston

Executive VP & Chief Investment & Strategy OfficerMr. Nathaniel Robinson

Executive VPMs. Noelle J. Perkins

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Robinson Nathaniel	See Remarks	May 12 '26	Sale	13.52	10,000	135,200	95,704	May 13 04:59 PM
Robinson Nathaniel	Officer	May 12 '26	Proposed Sale	13.52	10,000	135,234		May 12 10:22 AM
Robinson Nathaniel	See Remarks	Mar 03 '26	Sale	13.50	10,000	135,000	105,704	Mar 04 04:03 PM
Robinson Nathaniel	Officer	Mar 03 '26	Proposed Sale	13.50	10,000	135,000		Mar 03 02:34 PM
Robinson Nathaniel	See Remarks	Feb 27 '26	Option Exercise	0.00	14,005	0	119,661	Mar 02 04:11 PM
MCDONALD ANDREW R.	See Remarks	Feb 27 '26	Option Exercise	0.00	53,921	0	477,805	Mar 02 04:10 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 27 '26	Option Exercise	0.00	101,540	0	471,256	Mar 02 04:04 PM
JOHNSTON NEIL O	See Remarks	Feb 27 '26	Option Exercise	0.00	30,812	0	330,741	Mar 02 04:03 PM
Perkins Noelle J	See Remarks	Feb 27 '26	Option Exercise	0.00	15,406	0	78,471	Mar 02 04:02 PM
Sayed Laurida	See Remarks	Feb 27 '26	Option Exercise	0.00	5,602	0	23,116	Mar 02 04:01 PM
JOHNSTON NEIL O	See Remarks	Feb 25 '26	Option Exercise	0.00	146,337	0	358,070	Feb 27 04:53 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 25 '26	Option Exercise	0.00	202,877	0	481,907	Feb 27 04:52 PM
MCDONALD ANDREW R.	See Remarks	Feb 25 '26	Option Exercise	0.00	186,249	0	518,648	Feb 27 04:51 PM
Robinson Nathaniel	See Remarks	Feb 25 '26	Option Exercise	0.00	53,213	0	118,614	Feb 27 04:50 PM
MCDONALD ANDREW R.	See Remarks	Feb 23 '26	Option Exercise	0.00	34,878	0	350,336	Feb 24 04:13 PM
JOHNSTON NEIL O	See Remarks	Feb 23 '26	Option Exercise	0.00	27,405	0	220,132	Feb 24 04:10 PM
Robinson Nathaniel	See Remarks	Feb 23 '26	Option Exercise	0.00	9,966	0	68,272	Feb 24 04:10 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 23 '26	Option Exercise	0.00	37,992	0	300,033	Feb 24 04:09 PM
Sayed Laurida	See Remarks	Feb 23 '26	Option Exercise	0.00	2,492	0	18,377	Feb 24 04:08 PM
Sayed Laurida	See Remarks	Feb 22 '26	Option Exercise	0.00	6,661	0	18,191	Feb 24 04:08 PM
Perkins Noelle J	See Remarks	Feb 22 '26	Option Exercise	0.00	14,985	0	67,820	Feb 24 04:06 PM
Sun Angela	Director	Sep 05 '25	Sale	16.02	6,800	108,936	46,498	Sep 09 08:48 AM
Sun Angela	Director	Sep 05 '25	Proposed Sale	16.02	6,800	108,936		Sep 05 10:31 AM
MACKAY MICHELLE	Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	24,959	0	275,844	Jul 02 02:49 PM
MCDONALD ANDREW R.	See Remarks	Jul 01 '25	Option Exercise	0.00	10,697	0	320,890	Jul 02 02:45 PM
Perkins Noelle J	See Remarks	Jul 01 '25	Option Exercise	0.00	30,562	0	62,377	Jul 02 02:41 PM

LFST

LifeStance Health Group Inc

ODTX

Odyssey Therapeutics Inc

SION

Sionna Therapeutics Inc

LTH

Life Time Group Holdings Inc

CBLL

Ceribell Inc

CWK

Cushman & Wakefield Ltd

Upgrade your Finviz experience